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Cellular and Biochemical Events in Toll-like Receptor Signaling 
Abstract 
In multicellular organisms, communication between cells relies on transmitting 
information across membrane barriers. Different cell types interrogate particular aspects 
of their surrounding environment through protein receptors that span membranes and 
upon ligand binding, trigger enzymatic signaling cascades that culminate in the 
activation of one or more transcription factors. Information transmission is bidirectional, 
as individual cells must be able to sense unique aspects of their surroundings, relay 
their specialized knowledge with others, and receive the collective knowledge of 
surrounding cells and tissues. This two-way communication is particularly important in 
the innate immune system, where potentially infectious organisms must be readily 
detected and identified, and their presence communicated to other cells in the vicinity. 
Because of the rapid generation time of microorganisms, delays between any of these 
steps - detection, information processing or information transmission - can make the 
difference between successful control of infection and pathogen outgrowth. For this 
reason, the receptors that identify potential pathogens must be able to detect pathogens 
wherever they are found, be exquisitely sensitive, and initiate a robust response. At the 
same time, the inflammatory response to infection is itself damaging. This requires that 
the same receptors are tightly controlled, both by modulating their sensitivity and by 
rapidly turning off responses through negative feedback pathways. Here, I show that the 
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toll/interleukin-1 receptor domain-containing adaptor protein (TIRAP) plays a critical role 
in controlling the sensitivity of toll-like receptor (TLR) signaling. First, TIRAP controls the 
assembly of the myddosome, a protein complex that activates signal transduction, from 
both the plasma membrane and within endosomes of macrophages. Though TIRAP’s 
role at the cell surface was previously described, its endosomal function was previously 
unknown. Second, TIRAP is an important target for negative regulation. After 
stimulation with the TLR4 ligand lipopolysaccharide (LPS), macrophages induce a state 
known as endotoxin tolerance, in which they are refractory for additional LPS 
stimulation. Many mechanisms for endotoxin tolerance have been proposed, but here I 
show that TIRAP is degraded in endotoxin tolerance, and that the mechanism of TIRAP 
degradation also has implications for viral/bacterial superinfection.  
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Chapter 1: Innate Immunity and Toll-like Receptor Biology 
1.1 Introduction 
Adaptive immunity 
In the 200 years since Edward Jenner demonstrated that prior infection with cowpox 
could render an individual immune from smallpox, immunologists have expended a 
great deal of energy investigating how the immune system recognizes and responds to 
the presence of infectious microorganisms, and develops the immunological memory 
that makes such vaccination possible. Though Paul Ehrlich and Ilya Metchnikov shared 
the Nobel Prize in 1908 for their discoveries of antibodies and phagocytosis respectively, 
throughout most of the 20th century, there was a bifurcation in investigation of these 
types of immunity 1. The immune processes typified by antibody production, carried out 
primarily by B- and T-lymphocytes, and involving specific recognition of pathogens by 
distinct groups of clonal receptors are collectively referred to as "adaptive immunity." 
The other branch, typified by phagocytosis and carried out primarily by myeloid cells, is 
referred to as "innate immunity," and involves non-specific recognition and elimination of 
microbes generally. 
Adaptive immunity is made possible by receptors that are generated from random 
rearrangements of chromosomal DNA at specific genetic loci 2,3. B-cell receptors 
(BCRs), which are produced in soluble form as antibodies upon B-cell activation, are 
capable of recognizing a functionally limitless number of chemical shapes 4. In fact, B-
cells may bind to synthetic molecules not produced in nature 5,6. T-cell receptors (TCRs) 
are in principal equally diverse. However, during normal development, T-cells are 
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subjected to selective pressure such that only TCRs capable of binding to class 1 or 
class 2 major histocompatibility complexes (MHC-I and MHC-II) are provided with 
survival signals 7. Mature T-cells therefore recognize antigenic peptides that are 
presented in grooves of MHC molecules and thus are considered "MHC restricted." 
During a productive immune response, T-cells and B-cells capable of binding to ligands 
of the offending microbe are activated and undergo clonal expansion - a rapid series of 
mitotic divisions on a per-cell basis 8,9. Because their receptors are rearranged at the 
level of the chromosome, this clonal expansion produces a large population of identical 
cells, all capable of recognizing the current infectious organism. In the case of B-cells, 
clonal expansion is accompanied by affinity maturation, in which activation-induced 
cytidine deaminase (AID) introduces mutations to the locus of the binding site of the 
BCR 10. Those mutations that increase affinity of the resultant gene product are 
positively selected, while those clones that express mutations that decrease affinity are 
deleted from the repertoire. Though the antibodies present at the end of this process 
are different and in principal better at binding to the infectious agent, these antibodies 
can still be considered "clonal" since they arose from the same set of chromosomal 
rearrangements. 
Once an infection has been resolved, previously clonally expanded T- and B-cells 
undergo a contraction phase, but a minority differentiate to display a "memory" 
phenotype that are capable of rapidly responding to subsequent infectious challenge of 
the same microbe 11. These memory cells are also responsible for the success of 
vaccination, since exposure to dead or weakened versions of an infectious agent can 
 
3 
still generate a productive memory response that will respond upon encounter with the 
actual infectious agent. Though many details of these processes had yet to be 
experimentally resolved, much of the underlying framework for understanding adaptive 
immunity and the generation of clonal populations of T- and B-cells with unique 
receptors had been elucidated by the penultimate decade of the 20th century 1. 
The Janeway Hypothesis 
It was at this stage of development in immunological understanding that Charles 
Janeway addressed the Cold Spring Harbor Symposium on the immune system in 1989, 
stating 
I believe it is safe to state that our understanding of immunological 
recognition is approaching some sort of asymptote, where future 
experiments are obvious, technically difficult to perform, and aim to 
achieve ever higher degrees of precision rather than revolutionary 
changes in understanding. 12 
This claim has largely been vindicated by the following twenty five years of immunology 
research into T-cell and B-cell recognition of their cognate ligands. However, Janeway 
also introduced an apparent conundrum. Previously, immunologists believed that 
adaptive immune self/nonself discrimination was conferred during T- and B-cell 
development, when lymphocytes with self-reactive receptors would be deleted from the 
repertoire 1,12. According to this clonal selection theory, this process of negative 
selection (now called central tolerance) was sufficient to establish the immunological 
distinction between self and nonself. Thus, all foreign molecules should be equal with 
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respect to immunogenicity. However, Janeway noted that a foreign protein or peptide 
alone could not initiate an adaptive immune response, and that immunization requires 
inclusion of adjuvants - molecules from dead microorganisms - to elicit activation of T- 
and B-cells, antibodies, antigen-specific killing, and memory 12. 
In addition to the activating signal provided by BCR or TCR binding to their cognate 
ligand (signal 1), immunologists knew that B-cells and T-cells required a signal from 
antigen presenting cells (in the case of T-cells) or from previously activated helper T-
cells (in the case of B-cells) 9. This so-called "signal 2" was not provided by naïve cells, 
but several microbial molecules could imbue myeloid cells like dendritic cells with the 
ability to provide this co-stimulation. Janeway hypothesized that potentially infectious 
microorganisms might present the immune system with chemical patterns that would 
identify when an infection was underway. The presence of these pathogen-associated 
molecular patterns, or PAMPs, would elicit signal 2, while the absence of PAMPs would 
be a cue that any activated B- or T-cells receiving signal 1 alone were likely auto-
reactive. 
In order to be proper determinants of infection, Janeway hypothesized that PAMPs 
would have to be common to large numbers of infectious microbes, since by definition, 
there would be a limited number of receptors that could respond to them 12. Furthermore, 
these ligands must be unique to microorganisms, since ligands present in the absence 
of potential infection could generate inflammation and adaptive immune responses to 
self or to innocuous proteins. Janeway also proposed a theoretical framework for the 
receptors that would recognize PAMPs, which he called pattern recognition receptors or 
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PRRs. In contrast to B- and T-cell receptors, which are expressed on specialized cells 
and are randomly generated, PRRs should, he argued, be encoded in the germline and 
evolutionarily selected to recognize only microbial ligands. In addition, these receptors 
should be expressed on multiple cell types to detect pathogens in any context. 
Thus, Janeway provided a conceptual link between innate and adaptive immunity, and 
the experimental evidence of the last quarter century have confirmed this hypothesis. 
Mammalian immune cells express many different classes of PRRs, which recognize a 
diverse set of PAMPs (see Chapter 1.3), and it is clear that PRRs are critical in the 
activation of adaptive immune responses through induction of inflammation. 
Inflammation 
The clinical signs of inflammation were famously described by the Roman physician 
Celsus as Dolor, Calor, Rubor and Tumor, or pain, heat, redness and swelling 13. Today, 
we know that these symptoms are associated with activities of the immune system that 
promote pathogen control and clearance. The modern molecular definition of 
inflammation refers to the production of particular chemical messengers such as 
cytokines and chemokines, which are secreted in response to tissue damage or 
infection 14,15. These proinflammatory molecules promote pathogen clearance in a 
number of ways; they upregulate phagocytosis, increase vascular permeability, recruit 
monocytes and lymphocytes from circulation, up-regulate antigen presentation and co-
stimulatory molecules for activating the adaptive immune system, and have direct 
effects on skewing adaptive immune cell differentiation. 
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Some cytokines have pleiotropic effects, both on local tissues and systemically. For 
example, in response to recognition of PAMPs, macrophages produce and secrete the 
cytokine tumor necrosis factor α (TNFα) 16. Locally, TNFα can induce infected cells (or 
cells under other types of stress) to undergo programmed cell death 17. Vascular 
endothelial cells respond to TNFα by loosening tight junctions to increase vascular 
permeability18,19, permitting increased immune cell recruitment, as well as increasing 
expression of adhesion molecules 20. TNFα can also activate dendritic cells 21 and 
macrophages 22, causing numerous transcriptional changes including production of 
other proinflammatory cytokines by macrophages. TNFα signaling also increases 
expression of prostaglandin E2 (PGE2) 23, which circulates to the hypothalamus and 
induces fever. 
Other cytokines induced by PRRs have more direct effects on the outcomes of 
activation of the adaptive immune system. For example, macrophages and other 
myeloid cells also produce IL-12 in response to PAMP stimulation 24,25. Though IL-12 
can have local effects, such as activation of natural killer (NK) cells 26, the primary role 
of IL-12 is thought to be in skewing the differentiation of naïve CD4+ T-cells towards a 
Th1 phenotype 27. Thus, these cytokines may be considered "signal 3," complementing 
clone-specific recognition of ligand (signal 1) and PAMP-dependent co-stimulation 
(signal 2). Several cytokines combine local innate functions and effects directly on T- 
and B-lymphocytes. Like TNFα, IL-6 is a pyrogen 28, and acts on vascular endothelium 
to induce permeability 29. However, IL-6 also plays roles in CD4 T-cell differentiation, 
acting in concert with transforming growth factor β (TGFβ) to permit T helper 17 (Th17) 
skewing 30. 
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Chemokines are a subset of immune signaling molecules that are responsible for 
mediating chemotaxis, or the movement of cells 14. Like cytokines, chemokines can be 
generally divided into those that primarily act locally to promote pathogen clearance, 
and those that primarily mediate T-cell and B-cell function. Also as with cytokines, there 
is significant overlap in these categories. IL-8 (also called neutrophil chemotactic factor) 
is a potent chemoattractant for circulating neutrophils and promotes inflammation 31, 
while CCL19/CCL21 and CXCL13 establish gradients in order to divide lymph nodes 
into T- and B-zones respectively 32. Naïve CD4 T-cells express the chemokine receptor 
CCR7, which binds CCL19/21 and allows the cells to home to the T-zone 33. Differential 
expression of chemokine receptors on immune cells can have dramatic functional 
consequences, as when activated CD4 T-cells stop expressing CCR7, and upregulate 
CXCR5, allowing them to move into the B-cell zone where they provide help to activated 
B-cells 32. 
Interestingly, production of cytokines and chemokines (or chemokine receptors) that act 
locally to promote inflammation and those that act distally to permit activation of 
adaptive immunity are often differentially regulated. Inflammation may occur in the 
absence of microbes, but for Janeway's hypothesis to be correct, that inflammation 
should not lead to a productive adaptive immune response. Indeed, while TNFα may be 
produced in response to non-microbial stimuli such as sterile tissue damage 34, IL-12 is 
typically only produced downstream of the activation of PRRs. Of note, TNFα alone may 
activate dendritic cells to produce signal 2 co-stimulatory molecules, but in the absence 
of signal 3, no productive differentiation can occur. Thus, inflammation has at least two 
molecular states - that induced by PAMPs, and provides signal 2 and signal 3, and that 
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associated with non-microbe induced inflammation that does not provide signal 3. This 
latter non-infectious inflammation may indicate danger, but not infection, and the 
instigating signals are called "danger-associated molecular patterns" or DAMPs. 
1.2 Macrophages and Other Professional Microbe Detectors 
Many cell types can sense potentially infectious microorganisms and signal the 
presence of those microbes to surrounding cells. However, the majority of these cell 
types are only capable of sensing an infection within themselves, through receptors that 
interrogate the cytosol, and secrete a limited array of cytokines and chemokines. A 
much smaller number of cell types express the larger suite of receptors that enable 
detection of pathogens wherever they are found, and are capable of initiating a robust 
inflammatory response. In particular, the professional phagocytes - macrophages, 
dendritic cells and neutrophils - express many classes of PRRs, and are capable of 
activating the adaptive immune system both through cytokines and through the 
expression of costimulatory molecules. 
Macrophages 
Cells that could engulf and destroy microbes were first described by Ilya Metchnikov in 
the early twentieth century in starfish embryos. We now know that these phagocytes 
(literally: eating cells) play important roles in both pathogen clearance and wound repair. 
This is somewhat paradoxical, in that pathogen clearance necessitates a pro-
inflammatory response, but inflammation itself can damage tissues. Therefore, resolving 
a wound requires an anti-inflammatory state 35. The dual roles of macrophages in pro- 
and anti-inflammatory responses may be best understood as promoting tissue 
 
9 
homeostasis. In order to recover from perturbations caused by injury, the first priority 
must be to clear potentially infectious microorganisms, since pathogens may represent 
a persistent threat to tissue health if allowed to persist. In this circumstance, an 
inflammatory response is appropriate, though additional damage from inflammation may 
occur. Indeed, the first stage of wound healing is characterized by inflammation and 
infiltration of leukocytes 35. Once the threat of infection is cleared however, continued 
inflammation is deleterious, and an active anti-inflammatory response must ensue to 
heal the initial injury and prevent further damage. 
Macrophages are tissue-resident phagocytes that are present at steady state in almost 
every tissue. Though given different names depending on location, macrophages in all 
tissues share features that make them distinct from other cell types. Lineage tracing 
studies suggest that bone marrow stem cells differentiate into monocytes, which leave 
the bone marrow and circulate in blood 36. Monocytes are recruited into tissues from the 
blood and may differentiate further into myeloid dendritic cells or macrophages. 
As implied by their name (literally: big eater), macrophages are highly phagocytic. They 
express a broad range of scavenger receptors that allow them to bind to apoptotic cells, 
cell debris, infectious microorganisms and complement-opsonized particles 37. Their 
phagocytic ability even extends to inorganic materials such as uric acid crystals 38, 
carbon nanotubes 39, and tattoo ink 40. Additionally, the phagocytic compartment of 
macrophages is superbly degradative, and they may be identified by high expression of 
several lysosomal enzymes, such as lysozyme M 41. Though other cell types (such as 
neutrophils) that share these phagocytic and degradative abilities may be recruited to 
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tissues under inflammatory conditions, macrophages are unique in being present in 
tissues at steady state. 
Though the ability of macrophages to engulf and destroy unwanted materials plays a 
role in the normal functioning of tissues, immunologists primarily consider this feature in 
its pathogen-clearing context. Yet the immunological role of macrophages does not end 
at direct microbial clearance (Figure 1.1). These cells also possess a wide variety of 
other effector functions important to the immune system. Depending on tissue type, 
macrophages may express every known pattern recognition receptor thus far described 
(See Chapter 1.3), and produce large amounts of cytokines and chemokines in 
response to PAMPs. Macrophages also express both Class-I and Class-II MHC and 
when activated, the T-cell costimulatory molecules CD80 and CD86 42, allowing them to 
function as  antigen presenting cells for the maintenance of adaptive T-cell responses in 
an infected tissue. 
This diversity of macrophage function extends even further, as their behavior may be 
modified by the cytokine milieu in their vicinity. Under steady-state conditions, 
macrophages are thought to exhibit a naïve or M0 phenotype 43, characterized by active 
phagocytosis and macropinocytosis, and non-inflammatory clearing of apoptotic cells. In 
response to the cytokine interferon-γ (IFNγ), these cells differentiate into a “classically 
activated” or M1 state 44-46. M1 macrophages increase phagocytosis, increase 
lysosomal degradation by up-regulating nucleases and proteases, become more 
bactericidal due to increased production of reactive oxygen species (ROS) through  
Pathogen clearance
Inflammatory cytokine
production
Antigen Presentation
and T-cell Priming
Anti-inflammatory
cytokine production
Tissue remodeling Type I interferon
production
Figure 1.1 Macrophages are responsible for tissue homeostasis.
Macrophages (MΦ) participate in microbial clearance, inflammatory cytokine and inter-
feron production, and other immune-activating activities. However, they may also 
produce anti-inflammatory cytokines, and engage in tissue remodeling to promote 
wound healing. Other immune cells like neutrophils (NΦ), classical dendritic cells (cDC) 
and plasmacytoid dendritic cells (pDCs) are more specialized for a subset of these 
functions. 
Figure 1.1
cDC
pDC
ΝΦ
ΜΦ
Fibroblasts
11 
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expression of inducible nitric oxide synthase (iNOS), and produce more cytokines in 
response to PAMPs. 
“Alternatively activated” or M2 macrophages were initially described 47 as the opposite 
of M1 polarization, reflecting the distinction between type-1 and type-2 T-helper cell 
phenotypes. The inducer of M1 differentiation, IFNγ is a prototypical Th1 cytokine, while 
M2 differentiation can be accomplished with the Th2 cytokines interleukin 4 (IL-4) and 
IL-13 43. In addition, M2 macrophages express arginase, which antagonizes ROS 
production by diverting the substrate arginine away from iNOS, reminiscent of the 
mutually exclusive expression of opposing transcription factors in T-helper cell 
differentiation. However, it has become increasingly clear that this simple dichotomy is 
not sufficient to describe macrophage polarization. First, several different stimuli seem 
to induce “alternative” activation and the expression of the signature arginase, yet these 
stimuli do not result in identical macrophage phenotypes. Some have suggested sub-
designations of M2 for IL-4/IL-13 induced (M2a), immune-complex induced (M2b), and 
IL-10 induced (regulatory macrophages) but these classifications do not reflect the full 
complexity of macrophage differentiation 46. 
Second, the term “differentiation” may not even be appropriate, as the plasticity of these 
phenotypes in vivo has not been readily established. T-helper cell differentiation is 
largely uni-directional, as transcription factors called “master regulators” are necessary 
for expressing Th1, Th2, Th17 and Treg effector functions 48-52, and these master 
regulators largely preclude expression of the others 53 (though even with T-helper cells, 
evidence of some plasticity continues to mount 54,55). No equivalent master regulators 
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have been described for macrophages. Further, while T-cells have clonally selected 
unique receptors and are likely to be required only in response to a single type of 
infection, as described above, macrophages have many diverse functions in the same 
tissue. While it is possible that activated macrophages might execute their effector 
function and then die, to be replaced by newly differentiated monocytes, experimental 
evidence suggests that tissue-resident macrophages are incredibly long-lived 56,57. 
Further complicating these classifications, as discussed above, macrophages have 
important roles in homeostasis. Capable of expressing matrix metalloproteases and 
other extracellular matrix (ECM) modifying enzymes 58,59, macrophages home to sites of 
tissue injury where they eliminate dead or dying cells and assist in reorganizing the 
tissue substratum in order to facilitate healing. Though I primarily focus on 
macrophages’ ability to promote inflammation and immune responses in this document, 
during wound healing, they also play an important role in suppressing immune 
responses to reduce inflammatory tissue damage. For example, in a mouse model of 
wound healing, specific depletion of macrophages caused prolonged neutrophil 
infiltration, increased inflammation, and decreased neoangiogenisis and wound 
contraction 60. These macrophages have in some cases been classified as regulatory 
macrophages or M2, yet the extent of the overlap is unclear 43. The anti-inflammatory 
roles of macrophages have also been extensively documented in the context of tumors, 
where so-called “tumor-associated macrophages” have a phenotype similar but distinct 
from wound healing and M2 macrophages and may suppress the T-cells to kill 
transformed cells 61,46. 
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Due to the diversity of functions of these cells, studying their role in innate immunity in 
vivo has a number of challenges. In this regard, in vitro differentiated primary bone 
marrow-derived macrophages (BMDM) are an incredibly useful tool to study PRRs. 
These cells are relatively easy to differentiate to high purity in tissue culture, initiate 
robust responses to PRR ligands, and can be efficiently transfected by nucleofection. In 
addition, these cells are uniformly naive, while macrophages and monocytes isolated 
from living animals may have previous exposure to PAMPs and activating cytokines. 
Despite the usefulness of these cells for experimental studies of toll-like receptors 
(TLRs), many biochemical approaches are problematic, as ectopic expression of many 
genes involved in TLR signaling induces spontaneous activation. For this reason, 
immortalized BMDM are a useful stand-in for studying the same processes 62,63. One 
can create immortalized cells of the same genetic backgrounds as primary cells 64, and 
stably transduce these cells via retroviral gene insertion, allowing selection for low 
levels of expression through the use of selectable markers 65. 
Neutrophils 
Neutrophils are professional phagocytes that are recruited from circulation to inflamed 
tissues. This recruitment is mediated by chemokine and integrin signaling, initiated by 
tissue-resident cells 66. Unlike macrophages, which have several homeostatic roles, 
neutrophils are specialized for pathogen clearance, with a high rate of phagocytosis, 
high degradative capacity, and expression of many PRRs that are capable of inducing 
inflammatory cytokine production 67,68. Neutrophils also have the ability to undergo a 
unique form of programmed cell death that aids in the clearance of pathogens 69. Upon 
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microbial encounter, neutrophils may expel their genomic material in the direction of 
microbes, trapping them in DNA. These neutrophil extracellular traps (NETs) are 
microbicidal, and are important for clearing several extracellular bacterial infections. 
Classical Dendritic Cells 
Classical dendritic cells (cDCs), like macrophages, are tissue-resident phagocytes and 
are found in most tissue contexts, but like neutrophils, the primary role of cDCs is 
immunological, rather than homeostatic 70. However, though cCDs are capable of 
detecting microbial ligands and of producing inflammatory cytokines in response, unlike 
macrophages and neutrophils, cDCs do not play a significant role in direct pathogen 
clearance. Instead, cDCs seem to endocytose particles for the express purpose of 
presenting them to cells of the adaptive immune system. Upon activation by 
inflammatory cytokines like TNFα or to PAMPs, tissue-resident cDCs migrate to tissue-
draining lymph nodes in order to present local antigens to T-cells 71. 
Plasmacytoid Dendritic Cells 
Though named dendritic cells due to expression of the cell surface marker CD11c 72, 
plasmacytoid dendritic cells pDCs are functionally and developmentally distinct. The 
name itself is a contradiction, as both "plasmacytoid" and "dendritic" refer to opposing 
morphological features, and the stem cell lineage that gives rise to pDCs diverges from 
that of other myeloid cells very early, as evidenced by early presence of 9-O acetylated 
sialic acid (Netrevali I, thesis defense. Harvard University, 2014). Though pDCs have 
been shown to be capable of antigen presentation and T-cell priming 73, efficient 
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purification of pDCs from cDCs has been challenging, and some of the activity may be 
explained by contaminating cDCs. 
Plasmacytoid DCs are specialized to detect viruses and produce copious levels of type-I 
interferon (IFN) 74,75. Of note, pDCs are unresponsive to cell-surface TLR ligands (see 
Chapter 1.5), but have a specialized response to endosomal TLRs. Like macrophages, 
detection of viral nucleic acid by TLR7 and TLR9 in pDCs leads to the activation of 
NFκB and pro-inflammatory cytokine production. However, pDCs uniquely activate an 
additional signaling cascade that culminates in the activation of IRF7 76,77. Though 
macrophages are capable of activating this pathway when ligands are artificially 
delivered to the proper subcellular compartment 78, the physiological relevance of this 
pathway in macrophages is uncertain (See Chapter 1.5). 
1.3 Toll-like Receptors and other PRRs 
In order for the cells of the innate immune system to clear pathogens or activate the 
adaptive immune system, the first step is detecting that a pathogen is present. As 
Charles Janeway predicted over twenty years ago 12, germline encoded PRRs detect 
PAMPs to induce inflammation and activate adaptive immunity. In the past twenty years, 
immunologists have identified and characterized many such PRRs. PRRs exist in 
diverse locations within the cell, recognize a diverse set of ligands and activate a 
diverse set of signaling pathways and transcription factors. However, these PRRs all fit 
within the conceptual framework delineated by Janeway in 1989. 
Mammalian PRRs can be classified along several criteria, with the most obvious 
delineation separating transmembrane receptors that survey the extracellular milieu for 
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the presence of potentially infectious microorganisms, and the intracellular receptors 
that are poised to detect the presence of actual infections within an individual cell 
(Figure 1.2) 79. The former group, consisting of toll-like receptors (TLRs) and c-type 
lectin receptors (CLRs), are largely restricted to professional immune myeloid cells such 
as macrophages and dendritic cells. Since any cell can in principal be infected, the later 
group, whose two main families are the RIG-I-like receptors (RLRs) and the NOD-like 
receptors (NLRs), are found expressed at steady state in most cell types, though their 
expression can be substantially enhanced when cells are exposed to several 
inflammatory cytokines. 
Toll-like Receptors 
The earliest discovered and still best characterized PRRs are the toll-like receptors 
(TLRs). The gene toll was initially described in the fruit fly Drosophila melanogaster as 
being involved in development during dorsal-ventral patterning in fly embryos 80. In 1996, 
Bruno Lemaitre in Jules Hoffman’s lab showed that Toll was involved in the immune 
recognition of fungal pathogens in flies 81, a discovery for which Hoffman was granted 
the Nobel Prize in 2011. Toll signaling leads to activation of Dorsal, the homologue of 
mammalian nuclear factor kappa B (NFκB). During development, there is a gradient of 
Toll signaling that establishes the dorsal-ventral axis of the embryo, but in the adult fly, 
the receptor detects fungal pathogens and induces expression and secretion of 
antimicrobial peptides such as drosomycin and metchnikoin. 
Nicholas Gay and Fionna Keith recognized that the intracellular domain of Drosophila 
toll was similar to that of mammalian interleukin-1 receptor (IL-1R) 82. Since activation of  
Figure 1.2
Figure 1.2 Pattern Recognition Receptor and Toll-like Receptor Signaling
PRRs trigger signaling cascades that lead to the activation of many transcription factors, 
including NFκB and IRFs (left). TLRs in particular (right) utilize the adaptor proteins 
TIRAP and MyD88 to recruit IRAKs in a large multimeric protein complex called the 
myddosome. IRAKs activated in the myddosome are capable of triggering a signaling 
cascade culminating in the activation of NFκB and AP-1.
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IL-1 in mammals led to inflammation and co-stimulatory activation, Charles Janeway 
and Ruslan Medzhitov suspected that a mammalian homologue of Toll might be an 
example of the pattern recognition receptors Janeway hypothesized. They subsequently 
showed that a constitutively active mutant of "human toll" (now TLR4) was capable of 
activating NFκB and co-stimulatory molecules in macrophages 83. Meanwhile, 
Alexander Poltorak in Bruce Beutler’s lab was attempting to map a well-known mutation 
in mice that rendered the strain insensitive to bacterial lipopolysaccharide (LPS). They 
showed that this mutation mapped to the locus encoding the murine equivalent of 
human Toll 84. This series of studies finally demonstrated the existence of a bona fide 
PRR and its cognate PAMP. 
Mammalian TLRs are single-pass transmembrane receptors with a leucine-rich repeat 
(LRR) ectodomain and a cytosolic toll/IL-1 receptor (TIR) domain. Upon ligand binding 
and receptor dimerization, TLRs recruit a series of adaptor proteins through heterotypic 
TIR-TIR interactions (Figure 1.2), which in turn activate signaling cascades that 
culminate in the activation of several transcription factors, including NFκB, AP-1 and 
interferon regulatory factors (IRFs) (see also Chapter 1.4). Most TLRs form homodimers 
85-88, though TLR2 instead forms heterodimers with TLR1 and TLR6 89,90. 
TLRs may be conceptually divided based on subcellular location of ligand binding. TLRs 
1, 2, 4, 5 and 6 first encounter their ligands at the cell surface, while TLRs 3, 7-9, and 
11-13 encounter their ligands in degradative endosomal compartments 91. This 
bifurcation in localization mirrors differences in the ligands for these receptors. Cell-
surface TLRs detect structural components of viruses, bacteria 92,93 and fungi, such as 
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LPS from the outer membrane of gram-negative bacteria (TLR4) 84, lipoproteins from 
gram positive bacteria (TLR2)94, and bacterial flagellin (TLR5) 95. By contrast, 
endosomal TLRs detect primarily nucleic acid ligands from microbial sources, such as 
unmethylated CpG-motif containing DNA (TLR9), single-stranded RNA (TLR7) 96 and 
ribosomal RNA (TLR13) 97,98. Neither the localization nor the ligand of TLR10 have been 
described. However, TLR10 was recently shown to act in concert with TLR2 in response 
to Listeria monocytogenes 99, suggesting that it may heterodimerize with TLR2 at the 
cell surface, analogously to TLR1 and TLR6. For more on the cell biology of TLRs, see 
chapter 1.5. 
RIG-I Like Receptors 
The RLR family consists of three members, the name-sake retinoic acid-inducible gene 
I (RIG-I), melanoma differentiation-associated 5 (MDA-5), and RIG-I-like receptor 3 
(RLR-3) 100. All three of these RLRs contain RNA-helicase domains and bind RNA 
ligands in the cytosol. The precise nature of these ligands is unknown, though RIG-I 
seems to preferentially bind to uncapped 5' triphosphate RNAs of viral origin 101, while 
MDA-5 is thought to bind long branched RNAs, indicative of viral replication 
intermediates 102. Though these ligands typically originate from viruses with RNA 
genomes, some DNA viral genomes may be transcribed into RNA by RNA polymerase 
III, producing RNA ligands that can be recognized by RIG-I 103,104.  
Like TLRs, RLRs also rely on a receptor-proximal adaptor protein to initiate signal 
transduction, but in contrast to TLRs, which are transmembrane receptors and utilize 
non-membrane adaptor proteins, RLRs are cytosolic proteins that use a transmembrane 
21 
adaptor. Mitochondria-associated anti-viral signaling protein (MAVS), is associated with 
the membranes of mitochondria, peroxisomes, and mitochondrial associated 
membranes (MAMs) 62,100,105. The cell biology of RLR signaling remain largely unclear, 
but upon ligand binding, RIG-I and MDA-5 are thought to associate with MAVS via 
homotypic interactions of their respective caspase activation and recruitment domains 
(CARDs). MAVS then forms prion-like aggregates 106 that seem to be required for 
further activating Tank-binding Kinase 1 (TBK1), leading to the phosphorylation and 
activation of IRF3 and the production of type-1 IFN. MAVS may also activate several 
members of the TRAF family of ubiquitin ligases, leading to the activation of NFκB and 
pro-inflammatory cytokine production 107. RLR-3 does not have a CARD domain, and it 
is unclear whether it can participate in signaling alone, but seems to modulate the 
abilities of RIG-I and MDA-5 to trigger responses to certain ligands 108. 
Because all cells may be infected with viruses, RLR's have ubiquitous expression in 
most cell types that have been studied 109. Whenever a cell is infected, it is 
advantageous to initiate an antiviral response in the surrounding tissue, thus, most cells 
responding via RLRs are capable of producing type-I IFN. Detection of type-I IFN in 
surrounding cells induces expression of many anti-viral genes, including RLRs 
themselves, increasing the likelihood of timely detection should the infection spread. In 
addition, professional immune cells such as macrophages may produce 
proinflammatory cytokines, inducing a more robust immune response and the activation 
of the adaptive immune system 62,110. 
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NOD-Like Receptors 
The nucleotide oligomerization domain containing proteins (NOD1 and NOD2) are the 
prototypical members of a large class of intracellular proteins called the NOD-like 
receptors (NLRs) 111. NLRs are defined by the presence of a central NACHT domain, at 
least one leucine-rich repeat domain, and a variable C-terminal protein-protein 
interaction domain that may be a CARD (NLRCs) or a PYRIN domain (NLRPs). A small 
number of NLRs have a different C-terminal effector domain (NLRXs). The functions of 
NLRs are also quite diverse; in fact, not all NLRs are actually receptors. For example, 
CIITA is expressed in the nucleus of antigen presenting cells and is a transactivator of 
MHC class II expression 112. NLRC5 may play a similar role in MHC-I expression 113, 
though several other functions have been ascribed to it as well 114-116. The most PRR-
like NLRs are NOD1/2, which recognize bacterial outer membrane components found in 
the cytosol, and activate a signal transduction pathway culminating in the production of 
pro-inflammatory cytokines. Though long thought to be strictly cytosolic, NOD1 and 2 
are capable of recruiting autophagy factors to the plasma membrane 117. Localization to 
a site of bacterial entry makes sense, though whether signal transduction occurs from 
this location is unclear 79,91. 
Several other NLRs (NLRP1, NLRP3, and NLRC4) are also involved in signaling the 
presence of infectious microorganisms, but their status as true PRRs is unclear. Upon 
encountering their ligands, this group of NLRs act to assemble a large, multi-protein 
enzymatic structure known as the inflammasome, which culminates in the activation of 
caspase-1, the cleavage of pro-IL-1β and secretion of mature IL-1β. 118,119 For example, 
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upon activation, NLRP3 associates with the adaptor protein ASC, and forms a wheel-
like inflammasome oligomer 120. Both NLRP3 and ASC contain CARD domains, which 
are capable of recruiting pro-caspases 38,121. Caspases are proteases that are first 
produced as proenzymes, which have very low enzymatic activity until proteolytically 
cleaved. The formation of the inflammasome positions the procaspases such that they 
can act upon each other, causing full activation 121. 
The exact ligand(s) of NLRP3 are unclear, though several organic and inorganic stimuli, 
especially those that cause breaches in endosomal membrane integrity, are capable of 
activating it. The ligands of NLRP1 and NLRC4 are similarly obscure, and it is unclear 
whether these inflammasome-activating proteins truly recognize microbial ligands 
(PAMPs) directly, or if they merely recognize the signatures of microbe-induced damage. 
In particular, NLRC4 appears to act downstream of another NLR NAIP5, which detects 
cytosolic bacterial flagellin 122. Thus, NLRC4 may be thought of as an adaptor protein 
rather than a true PRR. 
An additional feature sets inflammasome activators apart from other PRRs: they do not 
appear to be capable of activating signal transduction pathways culminating in cytokine 
expression on their own. Inflammasome activation leads to the processing and 
secretion of IL-1β and IL-18, but transcription and translation of these cytokines are 
dependent on signals from other PRRs 63,119. For this reason, and because endogenous 
expression of inflammasome-activating proteins is quite low in resting cells, 
experimental investigation of these pathways is typically performed after treatment with 
TLR ligands, making definitive statements about the inflammasome's role in these 
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pathways complicated. An exception to this rule is AIM2, which is not itself a member of 
the NLR family, but which has been shown to bind directly to DNA, and is capable of 
activating both gene transcription and inflammasome activation in the absence of other 
PRRs 123,124. 
Other putative PRRs 
Like the inflammasome-activating NLRs, the status of c-type lectin receptors (CLRs) as 
bona fide PRRs is contentious. CLRs are expressed primarily on DCs, and recognize 
carbohydrate ligands 125. Though CLRs may bind to endogenous or microbe-associated 
ligands, only those that bind exclusively foreign carbohydrates could be considered 
PRRs. The best characterized consequences of CLR activation in the innate immune 
system do not involve direct activation of gene transcription. Instead, CLR activation 
seems to modify the response of other PRRs. For example, DC-SIGN (CD209) binds to 
mannose and fucose ligands found on several types of bacteria and fungi, and leads to 
phosphorylation and acetylation of the p65 subunit of NFκB, increasing its binding 
affinity for several target genes, and leading to (among other things) enhanced TLR-
driven IL-10 production 126. Though this activity itself is TLR-independent, actual 
transcription of IL-10 cannot proceed in the absence of other signaling pathways 
mediated by true PRRs. By contrast, several CLRs, including Dectin-1 have been 
shown to have the ability to induce transcription of TNFα and other cytokines directly, 
including those that influence T-cell activation and differentiation, suggesting that these 
receptors may be bona fide PRRs 127. It is possible that the large family of CLRs may be 
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similar to NLRs, in that some members act as PRRs in the classical sense, while others 
perform other immunomodulatory roles. 
Several other classes of proteins have been characterized that may claim to be 
members of the PRR pantheon, such as the cytosolic sensor of DNA called cyclic GMP-
AMP synthase (cGAS) 128,129. Upon binding to viral DNA, cGAS produces a cyclic 
dinucleotide second messenger, which is capable of initiating NFκB activation and type-
1 IFN production. Other putative cytosolic DNA sensors (CDS) such as AIM2 (see 
previous section) and IFI16 may play roles in sensing cytosolic viral DNA, though their 
role may be less important or cell-type specific 123,124,130,131.  
1.4 TLR Biochemistry 
Despite the growing understanding of many of these PRRs and their roles in pathogen 
detection, TLRs remain the most well characterized. In contrast to most transmembrane 
receptors, which initiate enzymatic signaling cascades through direct activation of 
signaling enzymes such as kinases, innate immune receptors and some 
proinflammatory cytokine receptors (such as TNFα receptor and IL-1R) do not engage 
directly with signaling enzymes, and instead rely on adaptor proteins. These adaptors 
have no enzymatic function, but instead act as a bridge between the receptor and 
downstream enzymes. Toll-like receptors in particular utilize not one, but two adaptor 
proteins: the sorting adaptors, which are hard-wired to the subcellular compartment 
where signaling is initiated, and the signaling adaptors, which bridge receptor and 
sorting adaptor to signaling enzymes. 
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Signaling Adaptors 
All TLRs are single-pass transmembrane receptors consisting of a leucine-rich repeat 
(LRR) ectodomain that mediates ligand binding, and a cytosolic TIR domain 132. In some 
cases, TLR ectodomains have been shown to bind directly to their ligands 133,134. By 
contrast, the affinity of TLR4 for LPS alone is weak and binding is mediated by a soluble 
accessory protein MD-2 135,136. Whether direct or indirect, TLR-ligand binding induces 
oligomerization (dimerization) of TLR ectodomains, and this initiates signaling through 
the interaction of cytosolic TIR domains 76,86,89,137. TIR domains are comprised of 5 
parallel beta sheets surrounded by 5 alpha-helices, and mediate homotypic protein-
protein interactions in TLR and IL-1R signaling. The signaling enzymes downstream of 
TLRs do not contain TIR domains, and are thus incapable of interacting directly with 
TLRs. Instead, they rely on signaling adaptors to bridge the TIR domain of the TLR to 
the protein-protein interaction domains of signaling enzymes (Figure 1.3). 
The most well studied of these signaling adaptors is myeloid differentiation 88 (MyD88), 
which is used by all TLRs save TLR3 91,138-140. MyD88 is relatively simple, consisting of 
a C-terminal TIR domain and N-terminal death domain (DD). Death domains are found 
in numerous proteins involved in apoptotic signaling, but also in the IL-1R-associated 
kinases (IRAKs), which are involved in TLR and IL-1R signaling downstream of MyD88. 
The DD of MyD88 interacts with the DD of IRAK4, which in turn associates with IRAK2 
in a large multimeric helical complex dubbed the myddosome 141. Myddosome assembly 
brings IRAKs into close proximity, which initiates auto-phosphorylation of the IRAKs, 
which in turn phosphorylate and activate TNF receptor associated factor 6 (TRAF6), an  
Figure 1.3
Figure 1.3 TLRs use sorting and signaling adaptors to couple receptor activation 
to intracellular signaling
See text for explanation.
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E3 ubiquitin ligase. TRAF6 builds a platform of K63-linked ubiquitin, which serves as a 
docking site for a number of other enzymes and related factors that ultimately activate 
the transcription factors NFκB and AP-1. 
MyD88-dependent TLR signaling is implicated in alternative pathways as well. As 
mentioned in Chapter 1.2, plasmacytoid dendritic cells are capable of activating a 
signaling pathway that culminates in the activation of IRF7 and the production of type-1 
IFN 76,77. This activity is related but distinct from activation of NFκB and proinflammatory 
cytokine production in these cells. While IRAK4 is required for activation of both 
transcription factors, IRAK1 is uniquely required for IRF7 activation and IRAK2 is 
uniquely required for NFκB activation, suggesting that there may be functionally distinct 
myddosomes 142,143. Indeed, IRAK1 knockout mice show enhanced inflammatory 
cytokine production from pDCs, while IRAK2 knockouts produce more type-1 IFN, 
suggesting that these enzymes may be competing for upstream activating signals.  
MyD88 is also required for signaling downstream of several other receptors. IL-1 and IL-
18 receptors also trigger MyD88-dependent signaling pathways requiring IRAK4, IRAK1 
and TRAF6, which activate NFκB 144,145. Further, MyD88 interacts with IFNγR and 
activates a MAPK-dependent stabilization of some IFNγ-induced transcripts 146. Though 
MyD88 can act downstream of TIR-domain containing receptors to stabilize transcripts 
containing AU-rich elements (AREs) 147, only the death domain of MyD88 is required for 
this activity downstream of IFNγR, suggesting that some other method of activation is at 
work. Finally, MyD88 is involved in tumorigenesis in the gut, as MyD88 knockouts are 
 
29 
resistant to tumor formation, though whether this can be attributed to MyD88's known 
functions or some novel pathway is unknown 148. 
The other TLR signaling adaptor is TIR domain containing adaptor protein inducing 
interferon (TRIF), but this adaptor is only used downstream of TLR3 and TLR4133,149. 
TRIF-dependent signaling events have been less well studied than those downstream 
of MyD88, but are capable of activating both IRF3 and the production of type-1 IFN as 
well as NFκB. Studies of TLR4, which is unique in its utilization of both MyD88 and TRIF, 
have shown that NFκB activation by both signaling pathways occurs in overlapping 
oscillations, providing prolonged activation.  
Sorting Adaptors 
Though the TIR of MyD88 is capable of interacting with the TIR of its upstream 
receptors, yeast 2-hybrid analysis suggests that the affinity of this interaction is quite 
low 150,151. In addition to their signaling adaptors, TLRs use sorting adaptors, so called 
because they are hard-wired to the site of signal transduction. In fact, these adaptors 
define the site of signal transduction, as they serve to couple ligand-bound receptors to 
their signaling machinery. Two such sorting adaptors have been defined for toll-like 
receptors. TIR-containing adaptor protein (TIRAP) has been shown to act downstream 
of TLR1/2, TLR2/6 and TLR4, linking these receptors to MyD88 152,153. TIRAP is a 
peripheral membrane protein consisting of a C-terminal TIR domain, with which it 
associates with the TIR domain of TLRs and of MyD88, and an N-terminal localization 
domain 154,155. 
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All of the TLRs initially described to require TIRAP are localized to the plasma 
membrane (See Chapter 1.5), and as initially described, TIRAP's 85 amino acid N-
terminus contains a 20 amino acid lipid binding motif containing four crucial lysines that 
mediate binding to phosphoinositol-4,5-bis-phosphate (PI(4,5)P2) 154. This phospholipid 
is enriched at the plasma membrane, specifically at membrane ruffles and sites of 
endocytosis. The only plasma membrane-localized TLR whose usage of TIRAP is in 
doubt is TLR5, though recent evidence suggests that TIRAP is likely used downstream 
of this receptor as well, though the signaling adaptor TRIF has also been implicated 
156,157. 
While TLR4 uses TIRAP to induce a MyD88-dependent signaling cascade at the cell 
surface, upon binding to LPS, TLR4 undergoes a CD14-dependent internalization and 
initiation of an additional TRIF-dependent signaling cascade from endosomes 158,159. It 
is in this signaling cascade that TRIF-related adaptor molecule (TRAM) is used. TRAM 
may be localized to both the cell surface and within endosomes, and contains a bipartite 
localization domain at its N-terminus, with a required myristolation motif and a polybasic 
domain that mediates association with the plasma membrane. To date, no plasma-
membrane associated function has been ascribed to TRAM in the context of TLR 
signaling, and indeed a mutant allele of TRAM that cannot associate with the cell 
surface shows enhanced TRIF-dependent signaling over its wild-type counterpart. 
However, recent evidence suggests that TRAM may function as a sorting adaptor for IL-
18 dependent signaling which is generally thought to occur from the cell surface, though 
the effects of localization of the adaptor were not directly assessed 160. 
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Until recently, no sorting adaptor for endosomal TLRs had been described. Aside from 
TLR4, which signals through both MyD88- and TRIF-dependent pathways, TLR3 is the 
only endosomal TLR to utilize TRIF, but TLR3 does not require the paired sorting 
adaptor TRAM. This is not surprising, as the affinity of TRIF's TIR domain for the TIR 
domain of TLR3 is quite high 150,151. Though the other endosomal TLRs signal via 
MyD88, like the cell surface TLRs, they have low affinity for its TIR domain, suggesting 
that an undefined sorting adaptor may exist. Experiments in TIRAP knockout animals 
initially excluded TIRAP as a candidate, since cytokine expression downstream of these 
receptors was not impaired. However, we recently showed that TIRAP is in fact required 
for endosomal TLR signaling, and that this fact was not apparent because of the use of 
artificial, non-degradable ligands for those studies (Chapter 2 and Ref 65). 
Negative Regulatory Mechanisms 
Inflammation may be deleterious to tissues, so preventing or reversing the effects of 
TLR signaling within cells are necessary. Indeed, negative regulatory mechanisms 
interfere with the biochemistry of TLR signaling at all stages of the pathway. Of note, 
several of these negative regulatory mechanisms interfere with the function of the 
adaptor proteins. For example, a splice variant of MyD88 (MyD88s), which lacks the 
flexible region connecting the TIR and DD, is upregulated by TLR signaling and acts as 
a dominant negative, blocking efficient recruitment of IRAK4 161,162. Sterile-alpha and 
armadillo motif-containing protein (SARM) is a TIR-domain containing adaptor protein 
that seems to interfere with TRIF-mediated signaling in a similar way 163. 
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The sorting adaptor TIRAP is also a target of negative regulation by cells of the innate 
immune system. Burton's tyrosine kinase (Btk) was shown to phosphorylate TIRAP 
downstream of TLR4 and TLR2 activation, and this phosphorylation is thought to recruit 
suppressor of cytokine signaling 1 (SOCS1) 164. SOCS1 is then believed to 
ubiquitinylate TIRAP, targeting it for proteasomal degradation. The protease caspase-1 
has also been shown to cleave TIRAP in response to signaling, though it remains 
unclear whether or not this cleavage is inhibitory 165. 
Inflammation is also harmful to infectious microbes, and many pathogens take 
advantage of the central role of TLR signaling in driving inflammation by targeting 
several nodes in the signaling pathway. The adaptor proteins in particular are tempting 
targets, since they mediate the most upstream signaling events. For example, the 
immediate early herpes simplex virus (HSV) protein ICP0 inhibits TLR signaling by 
targeting TIRAP for degradationvan 166. Bacteria also target TLR adaptors, including 
some that encode their own TIR-domain containing proteins. For example, like TIRAP, 
TcpB from Brucella is a phosphoinositide-binding protein that localizes to the plasma 
membrane and contains a TIR-like domain 167. This protein interacts with MyD88 and 
inhibits NFκΒ activation downstream of TLRs, though the precise mechanism is 
unknown 168. 
1.5 TLR Cell Biology 
Lipid bilayers segregate the exterior environment of a cell from the cytosolic contents. 
The ligand binding ectodomains of all TLRs face the extracellular space, but it has 
become increasingly clear that subcellular localization of TLRs is critically important for 
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their functioning and regulation. The most apparent segregation is between those 
receptors that reside and encounter ligands at the plasma membrane, and those that 
are primarily localized to endosomal compartments, but this distinction only tells part of 
the story, as more recent evidence suggests functionally distinct localization within 
these categories, as well as ligand-dependent movement that is critical for proper 
signaling. 
Biosynthetic Pathway 
TLRs are translocated into the endoplasmic reticulum (ER) during translation and 
exported to their ultimate destination. TLRs that reside at the cell surface are 
synthesized in an active form, though they are unlikely to encounter their ligands until 
reaching their final destination at the plasma membrane. Additionally, since their ligands 
are predominantly structural proteins unique to microorganisms, encounters with their 
ligands early in the biosynthetic pathway would still be indicative of infection, and 
signaling from other locations, if possible, would not be deleterious. 
By contrast, endosomal TLRs primarily detect nucleic acid ligands, which are abundant 
in non-pathological contexts 169. Though the nucleic acid structures that optimally 
stimulate these receptors are unique to microbes (as with unmethylated CpG DNA 
motifs detected by TLR9), many of these receptors are capable of responding to 
endogenous ligands if present in the right context 170. For this reason, endosomal TLRs 
require an additional biosynthetic step to acquire activity, namely cleavage of the 
ectodomain in lysosomes171,172. Restricting active endosomal TLRs to the endocytic 
environment decreases the potential for autoreactivity, as self-nucleic acids are readily 
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degraded in lysosomes. Indeed, ectopic expression of TLR9 at the cell surface allows 
macrophages to respond to self DNA that is typically not stimulatory 173. 
All TLRs require chaperones to mediate delivery from the ER. Though some factors in 
the secretory pathway are likely shared by other transmembrane proteins, several are 
used more narrowly by TLRs. For example, the ER-resident chaperone called gp96 is 
responsible for folding both cell-surface (TLR2 and 4) and endosomal TLRs (TLR9), as 
well as several members of the integrin family of receptors, but not other plasma 
membrane proteins. Indeed, cells deficient for gp96 are unresponsive to all TLR ligands, 
suggesting a critical role for all TLRs. TLR4 additionally requires protein associated with 
TLR4 (PRAT4A) in order to reach the cell surface 174. Despite its name, PRAT4A seems 
to be required for trafficking or folding more broadly, since deficient cells are 
unresponsive to ligands for all TLRs save TLR3 175. 
The most well studied factor regulating TLR trafficking specifically is a multipass 
transmembrane chaperone called Unc93B1, which is required for ER export for all 
endosomally-localized TLRs (Figure 1.4) 176,177. In the absence of Unc93B1, endosomal 
TLRs fail to load into COP-II coated vesicles, and are thus retained in the ER178. This is 
true for all endosomal TLRs that have been investigated, but distinct regions of 
Unc93B1 control differential post-golgi trafficking patterns. For example, the C-terminus 
of Unc93B1 is required to bind to adaptor protein 2 (AP-2), and that loss of this region 
causes an accumulation of golgi-modified, but uncleaved TLR9. AP-2 facilitates clathrin-
mediated endocytosis from the plasma membrane, suggesting that TLR9 is delivered to 
the cell surface and then endocytosed and delivered to lysosomes 179. Consistent with  
Figure 1.4
Figure 1.4 The biosynthetic pathway of TLRs
(1) TLRs are synthesized in the ER and loaded into COPII-coated vesicles, dependent 
on gp96 and other chaperones. TLRs destined for endosomes (right) require Unc93B1.
(2) After glycosylation in the golgi, some TLRs are exported to the cell surface
(3) Upon ligand binding, TLR4 undergoes CD14-dependent endocytosis
(4) TLR7 translocates directly from the golgi to lysosomes through its interaction with 
AP-4
(5) TLR9 is translocated to the cell surface by Unc93B1. At the cell surface, Unc93B1 
interacts with AP-2, which mediates endocytosis and translocation to lysosomes
(6) Cleavage by lysosomal proteases is required for activation of TLR7 and 9.
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this hypothesis, mutations in the YxxΦ motif in the c-terminus of Unc93B1 that 
abolished binding to AP-2 caused accumulation of TLR9 at the cell surface. 
Interestingly, though TLR7 also requires Unc93B1 for delivery to lysosomes, abrogating 
the interaction with AP-2 did not interfere with TLR7 trafficking. Instead, TLR7 binds 
directly to a different adaptor protein (AP-4), which appears to deliver TLR7 (and 
TLR11-13) directly to endolysosomes 178. 
Localization Post-Synthesis 
I previously described how TLRs may reside at the cell surface or within endosomes, 
but these broad characterizations do not encompass the full complexity of TLR 
localization. For example, TLR4 is localized to the cell surface at steady state, but is not 
capable of signaling from any location on the cell surface 154. As TIRAP is enriched on 
subdomains of the plasma membrane rich in PI(4,5)P2 TLR4 must be present in these 
locations in order to effectively induce myddosome formation. Further, even if TIRAP is 
artificially localized to other domains of the plasma membrane, this is not sufficient to 
allow signaling through TLR4 65,154. This suggests that TLR4 is preferentially localized to 
PI(4,5)P2-rich regions or rapidly recruited to those regions upon ligand binding. 
Consistent with the latter hypothesis, TLR4 is rapidly recruited to lipid rafts upon ligand 
engagement by CD14 159,180. One explanation for this signal-inducible movement is that 
it is an additional regulatory mechanism to ensure fidelity of signaling, as spurious 
receptor dimerization cannot lead to activation in the absence of intracellular signaling 
pathways. Though it is clear that signaling must occur from these regions, it is not clear 
whether exclusion from PI(4,5)P2 prior to ligand engagement has a regulatory purpose. 
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The best understood example of ligand-dependent movement also involves TLR4. 
Following ligand engagement at the cell surface and activation of the MyD88-dependent 
signaling pathway, TLR4 translocates to an endosomal compartment, whereupon it 
engages the TRIF-dependent signaling pathway 158. This process is also CD14-
dependent, and cells lacking CD14 lack the ability to activate TRIF signaling and type-1 
IFN production when encountering soluble ligand 159. This is true both for genetically 
deficient cells as well as cells that naturally lack expression of CD14, such as B-cells. 
Interestingly, TLR4 ligands on particles that can be phagocytosed in the absence of 
CD14 are capable of activating the TRIF pathway. Since B-cells typically restrict 
phagocytosis to particles that are bound by their clonal receptor, this may provide a 
useful regulatory mechanism whereby only B-cells specific for a particular antigen will 
be capable of triggering the TRIF pathway. 
Whether other surface TLRs undergo similar trafficking and signaling remains 
controversial. Inflammatory monocytes produce type-1 IFN in a TLR2-dependent 
manner in response to vaccinia virus and MCMV 181. As with TLR4, this IFN production 
is dependent on internalization, but relies on MyD88- and IRF7-dependent signaling 
rather than TRIF. This is similar to the MyD88-dependent IFN production in response to 
nucleic acid ligands in pDCs, indicating that multiple cell types have non-canonical 
specialization of TLR pathways 76,182. Though some investigators have reported TLR2 
internalization and IFN production in macrophages in response to particular bacterial 
ligands 183-185, these data have been disputed186 and we cannot reproduce these results 
in our lab. In any case, it is interesting to note that type-I IFN-producing signals never 
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originate at the plasma membrane, suggesting that internalization of receptors is an 
important regulatory step to preclude spurious induction. 
In pDCs, NFκB activation and IRF7-dependent IFN production appear to occur from 
different locations, as these signaling pathways can be dissociated by deletion of the 
adaptor protein AP-3; pDCs from mice lacking AP-3 fail to produce type-1 IFN, but have 
increased production of inflammatory cytokines 78. Interestingly, though macrophages 
do not usually produce type-1 IFN in response to TLR9 ligands, delivering CpG-DNA 
with the transfection reagent DOTAP causes macrophages to activate the IRF7 
pathway in an AP-3-dependent manner. The precise nature of these endosomes 
remains unclear, though the fact that delivery of ligand by transfection reagent is 
enough to rescue IRF7 activation in macrophages might indicate that trafficking of TLR9 
to IRF7 endosomes is independent of ligand. 
On the one hand, microscopic analysis suggests that stimulation with DOTAP-CpG 
induces AP-3-dependent migration from VAMP3+ early endosomes to LAMP2+ 
Lysosome-related organelles (LROs), suggesting that this movement is at least partially 
controlled by TLR signaling. On the other hand, the initial characterization of the effect 
of DOTAP on CpG trafficking shows that in the absence of DOTAP, IFN-inducing CpG 
collects in late endosomal compartments, while being distributed more evenly 
throughout the endosomal network in the presence of DOTAP187. These data are 
consistent with IFN production occurring from early endosomal compartments, and 
TLR9 may typically pass through these compartments too quickly in macrophages. 
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It is interesting to note that targeting TRAF3, an enzyme required for the IFN response 
downstream of TLR9, to endosomes rich in 3' phosphoinositides is sufficient to rescue 
the signaling defects of AP-3 knockout macrophages 78. This may suggest that the role 
of AP-3 is to deliver certain cytosolic signaling factors like TRAF3 to TLR9-containing 
endosomes, though these same data would also be consistent with delivery of TLR9 to 
endosomes that typically associate with TRAF3. In either case, this experiment 
suggests that IFN-producing endosomes are defined by association with some cytosolic 
factor(s), rather than the lumenal components of the endosome. It is possible that some 
as-yet unidentified sorting adaptors are responsible for assembling the needed signaling 
components differentially between these two different endosomes. 
1.6 Conclusion 
Only 25 years have passed since Charles Janeway first proposed pattern recognition 
receptors as a theoretical framework for understanding innate immune recognition, and 
less than 20 have passed since the first of these receptors was identified 1,12. Because 
this field has grown up in the modern genetic era, the trajectory of discovery for the 
important components of TLRs and other PRRs has followed a consistent pattern. 
Investigators used forward genetic analysis or large unbiased screens to identify 
molecules of interest, followed quickly by scouring the mammalian genome for related 
factors to investigate via reverse genetics. These approaches have been wildly 
successful, but I believe it is safe to echo Janeway's pronouncement on the fate of 
adaptive immune recognition in 1989 and say that our understanding of the genetics of 
innate immune recognition is approaching an asymptote. 
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Yet many exciting avenues of investigation remain. Subcellular localization of TLRs is 
clearly critically important to their function, yet our understanding is limited to a handful 
of receptors and a handful of cell types. Biochemical analysis of these pathways has 
been largely restricted to complementing genetic knockouts through ectopic expression. 
Since this approach often leads to spontaneous signaling, many questions regarding 
kinetics and ligand-dependency remain unresolved. Finally, most investigations of TLR 
signaling to date have relied on synthetic microbial ligands that ignore the full context of 
infection. Since many microbes contain many PAMPs, this approach has been useful to 
control for the actions of multiple separate pathways, but as described in the following 
chapter, it may also obscure important features of these pathways. 
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Chapter 2: A Promiscuous Lipid-binding Protein Diversifies the Subcellular Sites 
of Toll-like Receptor Signal Transduction 
2.1 Abstract 
The Toll-like receptors (TLRs) of the innate immune system are unusual in that 
individual family members are located on different organelles, yet most activate a 
common signaling pathway important for host defense. It remains unclear how this 
common signaling pathway can be activated from multiple subcellular locations. Here, 
we report that, in response to natural activators of innate immunity, the sorting adaptor 
TIRAP regulates TLR signaling from the plasma membrane and endosomes. TLR 
signaling from both locations triggers the TIRAP-dependent assembly of the 
myddosome, a protein complex that controls proinflammatory cytokine expression. The 
actions of TIRAP depend on the promiscuity of its phosphoinositide-binding domain. 
Different lipid targets of this domain direct TIRAP to different organelles, allowing it to 
survey multiple compartments for the presence of activated TLRs. These data establish 
how promiscuity, rather than specificity, can be a beneficial means of diversifying the 
subcellular sites of innate immune signal transduction. 
2.2 Introduction 
At some point in their existence, all proteins must move within mammalian cells. Some 
movement is biosynthetic, in that the protein must be transported from its site of 
synthesis on the ribosome to its site of action. Another type of movement is signal-
dependent, meaning that the protein will move from one location to another in response 
to some cellular stimulus. Classic cell biological studies identified the cis-acting 
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sequences that direct these types of protein movement within cells; for example188,189,190. 
In addition to these examples, a more complex type of protein movement exists, where 
proteins can be found in multiple locations under resting conditions, or can be recruited 
to multiple locations in response to a stimulus. In this latter instance, it is not obvious 
how a single localization signal would allow a protein to be targeted to (and function 
from) multiple organelles. An example of this can be found from the studies of the Toll-
like Receptors (TLRs) of the innate immune system.  
TLRs are transmembrane receptors that are expressed by a variety of mammalian cell 
types, but are best studied in professional phagocytes such as macrophages and 
dendritic cells (DCs) 191. TLRs detect a wide range of microbial products, and may be 
divided into different groups based on their subcellular site of ligand recognition 91. TLRs 
1, 2 and 4-6 reside at the plasma membrane, where they detect molecules displayed on 
the surface of various pathogens. TLRs 3, 7-9 and 11-13 are localized to various 
endosomal compartments, where most detect microbial nucleic acids.  
Despite residing in distinct subcellular compartments, most TLRs activate a common 
signal transduction pathway to induce innate and adaptive immunity. TLR signaling 
usually initiates with the activation of an adaptor protein called MyD88, which is 
recruited to the conserved TIR domain present in the cytosolic tail of all receptors of this 
family 137,192. MyD88 forms a protein complex with kinases of the IRAK family called the 
myddosome 141,193. This complex is thought to induce a cascade of signaling events that 
activates the NF-κB-dependent expression of cytokines, chemokines and other 
immunomodulatory factors 137,193,194. Because TLRs reside on distinct organelles, the 
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myddosome must have the capacity to be assembled in multiple subcellular locations. 
How myddosome assembly can be promoted from multiple locations is unknown. 
Answering this question will fill a fundamental gap in our understanding of how immune 
signaling pathways are integrated into the cellular infrastructure within which they 
operate.  
A simple explanation for how MyD88 can be recruited to diverse organelles would be 
through interactions with the TIR domains of activated TLRs. However, 2-hybrid 
analyses performed in yeast and mammalian cells indicated that MyD88 has limited 
ability to interact with TLRs directly 150,151. For this reason, an intermediate protein is 
likely required to link activated TLRs to the recruitment of MyD88. Consistent with this 
model, the cell surface TLRs utilize “sorting adaptors” to accomplish this task. Sorting 
adaptors are the only regulators of TLR signaling that are located at the subcellular site 
of signal transduction, prior to any microbial encounter 169. Their placement at the 
eventual site of signaling allows sorting adaptors to function as sensors of activated 
TLRs, and recruit downstream signaling adaptors (e.g. MyD88) to induce inflammatory 
cytokine expression. Most plasma membrane-localized TLRs use the sorting adaptor 
TIRAP (also known as Mal) to recruit MyD88 to the cell surface 152,154,195,196. The ability 
of TIRAP to function as a sorting adaptor is dependent on its amino terminal localization 
domain, which interacts with plasma membrane-localized phosphatidylinositol-4,5 
bisphosphate (PI(4,5)P2) and other lipids 154. The use of sorting adaptors extends 
beyond the MyD88-dependent pathways, as analogous systems exist in other immune 
signaling pathways in mammals and Drosophila melanogaster 158,169,197.  
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Despite the apparent importance of sorting/signaling adaptor pairs for controlling TLR 
signaling from the cell surface, a sorting adaptor for the exclusively endosomal TLRs 
has not been described. As such, it is unclear how MyD88-dependent innate immune 
responses are activated by endosomal TLRs. TIRAP was initially excluded as a sorting 
adaptor for endosomal TLRs because TIRAP-deficient cells retain the ability to respond 
to synthetic TLR7 and TLR9 ligands 152,196. However, these studies also demonstrated 
that the requirement of TIRAP for signaling from cell surface-localized TLRs can be 
bypassed when high concentrations of ligand are used. Primary macrophages and DCs 
are highly endocytic. This property, combined with the common use of 
phosphorothioate-linked (nuclease-resistant) nucleic acids to activate endosomal TLRs, 
led us to hypothesize that these ligands could accumulate to high concentrations within 
endosomes, masking a requirement for TIRAP. In light of this hypothesis, we decided to 
reassess the role of TIRAP in endosomal TLR signaling.  
Herein we report that TIRAP is required for signaling downstream of endosomal TLRs in 
response to natural ligands, such as viral nucleic acids. We show that TIRAP is present 
in myddosomes induced by both cell surface and endosomal TLRs, and is required for 
myddosome formation. Further, we show that the ability of TIRAP to bind to multiple 
lipid species is critical for its ability to function from multiple subcellular compartments. 
These findings provide a molecular explanation for the ability of MyD88 to be recruited 
to more than one organelle, and highlight how a promiscuous lipid-binding domain can 
be used to diversify the subcellular sites of innate immune signal transduction.  
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2.3 Results 
TIRAP is required for endosomal TLR signaling in response to viral infection 
To determine if TIRAP would function as a sorting adaptor for endosomal TLRs, we 
readdressed the genetic requirement for this protein in the signaling pathway activated 
by TLR9. TLR9 is an excellent model for these studies for two reasons. First, it is the 
best-characterized endosome-localized TLR 198 and its ligand (unmethylated CpG-
containing DNA) is easy to produce 199. Second, whereas several viruses activate TLRs 
at the cell surface and endosomes 92,181,200, substrains of herpes simplex virus (HSV) 
exist that only activate TLR9 93. Thus, TLR9 provides a useful model for the study of 
both synthetic (CpG DNA) and natural (HSV) activators of endosomal TLRs.  
Wild type (WT) and TIRAP-knockout (KO) primary bone-marrow derived macrophages 
(BMDM) were stimulated with CpG DNA or three substrains of HSV-1 93. The cell 
populations were then assessed for the expression of the cytokines interleukin-1β (IL-
1β) and IL-6. As expected 152,196, TIRAP KO BMDM had no defect in responding to CpG 
DNA, while their response to bacterial lipopolysaccharide (LPS), a ligand for the cell-
surface TLR4, was impaired (Figure 2.1A). Interestingly, whereas all three substrains of 
HSV induced the expression of IL-1β and IL-6 in WT BMDM, TIRAP KO BMDM were 
defective for these responses (Figure 2.1B). Among the HSV substrains tested, Kos A 
and Kos CE only engage TLR9, whereas Kos K engages both cell surface TLR2 and 
endosomal TLR9 93. Our finding that TIRAP is required for cytokine expression in 
response to HSV substrains that only engage TLR9 suggests that this adaptor plays a 
role in signaling from endosomal receptors. Interestingly, as was observed for ligands 
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Figure 2.1 TIRAP Is Required for Endosomal TLR Signaling in Response to Natural Ligands
(A and B) Primary WT or TIRAP KO BMDMs were treated with 100 ng/ml LPS or 1 mM CpG DNA (A) or 
infected with HSV (B) for 3 hr. Total mRNA was extracted and analyzed for expression of IL-1b and IL-6. 
Note that TIRAP KO BMDMs are defective in responding to natural ligands. N.S., cells that were not 
stimulated.
(C) Microarray gene expression profiles from sorted cDCs and pDCs were analyzed for transcripts 
associated with TLR signaling pathways. Values on the x axis represent the fold difference in gene 
expression between mDCs and pDCs. Gray area depicts equal gene expression in cDCs and pDCs. Note 
that TIRAP is expressed in pDCs comparably to cDCs, despite the absence of cell-surface TLRs. 
(D) pDCs from WT or TIRAP KO mice were infected with HSV-2 (186 syn+) at an moi of 1 or influenza 
(A/PR/8) at an moi of 10. Supernatants were collected after 24 hr and analyzed by ELISA. Error bars 
represent SD. See also Figure S1.
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that activate cell surface-localized TLRs 152, the requirement for TIRAP in TLR9 
signaling can be bypassed by increasing the dose of a subset of HSV substrains 
(Supplementary Figure S1A, MOI=10). The requirement of TIRAP for antiviral 
responses was unique to the TLR pathway, as WT and TIRAP KO BMDM expressed 
the interferon (IFN) inducible gene viperin comparably when infected with mammalian 
reovirus (Supplementary Figure S1B), a known activator of the cytosolic RIG-I like 
receptors 62. Collectively, these data suggest an important role of TIRAP in the 
response to natural (viral) activators of endosomal TLR9.  
To corroborate these findings, we sought an alternative cell type to study the role of 
TIRAP. Plasmacytoid dendritic cells (pDCs) are an intriguing option, as they exclusively 
utilize endosomal TLRs to detect infections 201. As such, all of the plasma membrane-
localized TLRs that are established to require TIRAP are non-functional in these cells 93. 
Moreover, in pDCs, endosomal TLRs exhibit an intriguing behavior in that they can 
induce cytokine and IFN production from different populations of endosomes, with IFN 
production occurring from endosomes rich in 3’ phosphoinositides 78. We reasoned that 
if TIRAP was not required for endosomal TLR signaling, as previously believed 152,196, 
then pDCs would have no need to express the gene encoding this adaptor. To address 
this possibility, a comparison of gene expression was performed between highly purified 
pDCs and conventional DCs (cDCs). This analysis revealed that pDCs express much 
lower levels of the cell-surface TLRs 1, 2, 4 and 6 than cDCs (Figure 2.1C). This 
observation may (in part) explain the inability of pDCs to respond to ligands for plasma 
membrane-localized TLRs 93. pDCs expressed higher levels of some endosomal TLRs 
(TLR7 and TLR12) than their cDC counterparts. Interestingly, both cell types expressed 
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comparable levels of TLR9, TIRAP and MyD88 (Figure 2.1C), suggesting that TIRAP 
may indeed have a function downstream of endosomal TLRs in pDCs. To address this 
possibility, pDCs were infected with either HSV or influenza virus, natural activators of 
endosomal TLR9 and TLR7, respectively 74,96. Infected cells were then assessed for 
their ability to induce the expression of IFNα or the cytokine IL-12p40. Because the 
expression of these cytokines is initiated from different populations of endosomes 78, 
this experiment allows us to determine if a population of endosomes exists that 
selectively requires TIRAP function. In comparison to WT pDCs, TIRAP KO pDCs were 
impaired in the ability to produce IFNα in response to HSV or influenza virus (Figure 
2.1D). In contrast, the production of IL-12p40 was not impaired in TIRAP KO pDCs, 
suggesting that TIRAP regulates signaling from endosomes that were previously 
defined as being rich for 3’ phosphoinositides 78. Another sorting adaptor may exist to 
control TLR signaling to induce IL-12p40. Overall, these data establish that, in response 
to natural activators of innate immunity, TIRAP is required for signaling by endosomal 
TLRs in multiple cell types. Furthermore, the use of HSV strains that only activate TLR9, 
and the use of pDCs that only permit signaling by endosomal TLRs, eliminates the 
possibility of contaminating bacterial products (e.g. LPS) explaining these observations.  
Immortalized macrophages are a model for investigating endosomal TLR signaling 
To define the means by which TIRAP regulates TLR signaling from multiple organelles, 
we sought a cell type that would be easy to propagate and amenable to genetic 
manipulation. Immortalized BMDM (iBMDM) have emerged as a useful tool in this 
regard, as they retain the signaling properties of their primary cell counterparts 62,63 and 
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TIRAP KO iBMDM have been used to dissect the functions of this adaptor 202. Similar to 
our observations made in primary BMDM, TIRAP was required for iBMDM to respond to 
several substrains of HSV, including two that engage only TLR9 (Kos A and Kos CE) 
(Figure 2.2A) 93. We found that iBMDM are less phagocytic than primary BMDM (Figure 
2.2B). This was expected, because endocytosis and phagocytosis rates are higher in 
non-mitotic macrophages (e.g. primary BMDM) than in dividing macrophages 203. We 
hypothesized that this lower phagocytic activity would prevent CpG DNA from building 
to high concentrations within endosomes, perhaps revealing a requirement for TIRAP in 
responses to synthetic TLR9 ligands. Indeed, while WT iBMDM responded to CpG DNA 
comparably to primary WT BMDM, TIRAP KO iBMDM were completely unresponsive 
(Figure 2C). However, high doses of CpG DNA partially overcame the requirement for 
TIRAP in these cells (Figure S1C). To determine if TIRAP deficiency was responsible 
for the unresponsiveness of these cells to TLR9 ligands, this adaptor was stably 
reintroduced into TIRAP KO iBMDM via retroviral transduction. The retroviral vector 
used also encodes an internal ribosomal entry site upstream of eGFP, which allowed for 
the use of fluorescence activated cell sorting (FACS) to isolate a population of cells with 
uniform levels of expression (data not shown). Rescuing TIRAP expression in TIRAP 
KO iBMDM restored responsiveness to plasma membrane and endosomal localized 
TLR ligands (Figure 2.2D). Furthermore, rescuing TIRAP expression enabled an 
enhanced response to all substrains of HSV examined (Figures 2.2A and S1D). Among 
the substrains examined is HSV 7134 (Figure S1D), which lacks the expression of ICP0 
166. ICP0 is an immune evasion protein that may interfere with TLR signaling by causing 
the degradation of TIRAP and/or MyD88 166. To determine if ICP0 is acting to prevent  
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Figure 2.2 iBMDM Responses to CpG DNA Mimic Primary Cell Responses to Natural Ligands
(A) WT, TIRAP KO, or TIRAP-expressing TIRAP KO iBMDMs were infected with indicated HSV strains 
(moi = 1) for 3 hr and analyzed by qPCR.
(B) Primary or iBMDMs were incubated with fluo- rescent beads at 37� C for the indicated times, and 
phagocytosis was analyzed by flow cytometry. Mean fluorescence intensity was plotted relative to cells 
incubated with beads on ice for 45 min.
(C) WT or TIRAP KO primary and iBMDMs were stimulated with 1mM CpG DNA. After 24 hr, superna-
tants were collected and analyzed for IL-6 by ELISA. N.D., no signal was detected.
(D) WT, TIRAP KO, or TIRAP-expressing TIRAP KO iBMDMs were treated with LPS or CpG DNA for 3 hr 
and analyzed by qPCR.
Error bars represent SD. See also Figure S1.
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TLR signaling in our assays, side-by-side experiments were performed with HSV 7134 
and an isogenic substrain whose expression of ICP0 was restored (7134R). We 
observed no difference in the ability of these strains to induce TIRAP-dependent 
cytokine expression (Supplementary Figure S1D). These data suggest that ICP0 may 
act at a later stage of infection or in a different cell type to interfere with TLR signaling. 
Overall, the observation that the signaling defects of TIRAP KO cells can be rescued by 
the expression of a TIRAP cDNA provides formal genetic proof of its role in signal 
transduction activated by endosomal TLRs. iBMDM therefore provide a genetically 
tractable model to study the role of TIRAP in signaling from endosomal TLRs through 
the use of natural and synthetic ligands.  
TIRAP promotes the assembly of myddosomes at the plasma membrane and 
endosomes.  
Based on the experiments described above, it was possible that TIRAP acts to 
assemble myddosomes after activation of TLRs found at the plasma membrane and 
endosomes. The crystal structure of the myddosome indicates that the adaptor MyD88 
is a core component of this signaling complex 141. However, the natural kinetics of 
myddosome assembly induced by TLR ligands remain undefined. To assess 
myddosome assembly, iBMDM were stimulated with LPS or CpG DNA, and 
endogenous MyD88 immunoprecipitates were subjected to western analysis for the 
presence of the other known components of the myddosome, the kinases IRAK2 and 
IRAK4 141,193. Within minutes of stimulating cells with either LPS or CpG DNA, both 
kinases were recruited to MyD88 (Figures 2.3A and 3B). Immunoprecipitations with  
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Figure 2.3 TIRAP Is a Critical Constituent of the Myddosome
(A and B) WT iBMDMs were stimulated with LPS (A) or CpG DNA (B) for the indicated times. MyD88 was 
immunoprecipitated (IP) from lysates and analyzed by western blot.
(C and D) TIRAP-transgenic iBMDMs were stimu- lated with LPS (C) or CpG DNA (D), and biotin- TIRAP 
was precipitated from cleared lysates with avidin-coated agarose before western analysis. (E) WT, TIRAP 
KO, or TIRAP-expressing TIRAP KO iBMDMs were treated with LPS for 1 hr or CpG DNA for 2 hr and 
analyzed as in (A). N.S., cells that were not stimulated.
See also Figure S2.
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IRAK2 antisera yielded comparable results, with MyD88 and IRAK4 being recruited to 
IRAK2 within minutes of stimulation (Figure S2A). Consistent with prior work on the 
activation of MAP kinases and NF-κB 138,152, LPS induced maximal assembly of the 
myddosome more rapidly than CpG DNA (Figures 2.3A and 3B). Because the 
myddosome is not detected in resting cells, its assembly can be used to monitor the 
earliest cytosolic events that occur during TLR signaling.  
To determine if TIRAP is a component of LPS or CpG DNA-induced myddosomes, we 
utilized the transgenic TIRAP KO cells described above. The TIRAP allele expressed in 
these cells contains a biotinylation sequence and an HA-epitope tag to facilitate 
biochemical analysis. LPS and CpG DNA-induced myddosomes containing IRAK4 and 
MyD88 could be detected by direct isolation of biotinylated TIRAP through the use 
avidin-coated beads (Figure 2.3C and 3D). Moreover, TIRAP could be recruited to 
MyD88-immunoprecipitates in LPS treated cells (Figure S2B). These data indicate that 
TIRAP is a stable component of the myddosomes induced by either TLR4 or TLR9.  
To determine if TIRAP was required for myddosome formation, TIRAP KO iBMDM were 
examined. Myddosome formation in response to both LPS and CpG DNA was impaired 
in TIRAP KO cells, but rescued in TIRAP KO cells expressing the TIRAP transgene 
(Figure 2.3E). These data establish that TIRAP controls the assembly of (and is a 
component of) myddosomes formed in multiple subcellular compartments. 
Promiscuous lipid binding diversifies the subcellular sites of TIRAP residence 
TIRAP is a peripheral membrane protein that is enriched at the cell surface 204. Our 
discovery that TIRAP regulates TLR signaling from endosomes therefore raises the 
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question of how a plasma membrane-localized adaptor can function from endosomes. 
The localization of TIRAP is strictly dependent on an amino terminal lipid-binding 
domain that interacts with acidic phosphoinositides (PIs) and phosphatidylserine (PS) 
204. To confirm these observations, the ability of TIRAP to bind lipids was assessed by 
PIP-strip analysis, which permits the identification of several possible protein-lipid 
interactions in a single experiment. GST-TIRAP interacted with all phosphorylated PIs 
and PS (Figure 2.4A). As a control for specificity of these interactions, we used a mutant 
that is defective for lipid-binding in vitro and localization in vivo (TIRAP 4X). This mutant 
TIRAP allele did not bind to any lipids in this analysis (Figure 2.4A). Among the lipids 
TIRAP interacts with, PI(4,5)P2 is considered solely important for its function in 
controlling signaling by plasma membrane-localized TLRs 155,204. In this regard, TIRAP 
is similar to many other lipid-binding proteins in that its ability to bind PIs promiscuously 
is not considered functionally significant 205.  
Because some of the lipids that TIRAP interacts with are enriched on endosomes (e.g. 
PI(3)P and PI(3,5)P2) 206, we considered the possibility that a pool of TIRAP would be 
located on endosomes. This possibility was addressed by examining the localization of 
the lipid-binding domain of TIRAP in primary BMDM. We transfected these cells with 
plasmids encoding the GFP-tagged lipid-binding domain of TIRAP (TIRAP-loc) along 
with a plasmid encoding a cherry-tagged pleckstrin homology (PH) domain from PLCδ1 
(PLC), which binds to PI(4,5)P2 uniquely 207. We reasoned that if TIRAP binds only to 
PI(4,5)P2 within cells, then the subcellular distribution of these two proteins should be 
identical. However, if TIRAP binds to more lipids than PI(4,5)P2, then the distributions of 
these proteins should be overlapping but distinct. Confocal microscopy revealed that  
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Figure 2.4 Promiscuous Lipid Binding Diversifies the Localization of TIRAP
(A) GST-tagged TIRAP or TIRAP 4X proteins were incubated with PIP strips containing various lipids 
(shown in left panel) and assessed for protein binding by far western analysis.
(B) TIRAP KO primary BMDMs expressing TIRAP loc-GFP and PLC-cherry were analyzed by confocal 
microscopy. All images are representative of at least three independent experiments where more than 
200 cells were examined per condition and >95% of the cells displayed similar staining. Selective local-
ization of TIRAP to intracellular vesicles compared to the PLCd1 PH domain demonstrates that TIRAP 
binds to multiple lipids.
(C) TIRAP KO primary BMDMs expressing TIRAP loc-GFP were analyzed by confocal microscopy. One 
image was captured every 20 s for 20 min. (C) Shows representative frames from one such capture (see 
Movie S1 for full-length movie).
See also Movie S1.
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both proteins colocalized extensively at the plasma membrane, which is an abundant 
site of PI(4,5)P2 207. Interestingly, TIRAP’s lipid-binding domain also labeled intracellular 
vesicles that were devoid of the PLCδ1 PH domain (Figure 2.4B, inset), suggesting that 
TIRAP binds additional lipid targets inside cells, as it does in vitro.  
To determine if the intracellular TIRAP-positive compartments were endosomes, live 
time-lapse microscopy was performed in primary BMDM expressing the GFP-tagged 
lipid-binding domain of TIRAP. Primary BMDM were highly active and exhibited 
extensive ruffling of the plasma membrane (Supplementary Movie). Numerous TIRAP 
positive vesicles were formed at these sites of membrane ruffling, and these vesicles 
accumulated Alexa-647 labeled dextrans that were added to the culture media shortly 
after imaging began (Figure 2.4C and S3). These data indicate that the lipid-binding 
domain of TIRAP is capable of localizing to the plasma membrane and bona fide 
endosomes. Promiscuous lipid binding by TIRAP may therefore be important for its 
ability to function as a sorting adaptor for TLRs located at the cell surface and 
endosomes.  
Distinct lipid targets of the TIRAP localization domain permit TLR signaling from the 
plasma membrane and endosomes. 
To determine the function of the individual lipids with which TIRAP interacts, the lipid-
binding domain of TIRAP was replaced with domains of singular specificity (Figure 2.5A, 
top panel). We replaced the endogenous lipid-binding domain of TIRAP with the PLCδ1 
PH domain described above, which binds exclusively to PI(4,5)P2 (hereafter referred to 
as PLC-TIRAP). By a similar strategy, a PI(3)P-specific TIRAP allele was generated  
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Figure 2.5 Promiscuous Lipid Binding by TIRAP Diversifies the Sites of TLR Signaling
(A) Confocal microscopic analysis of TIRAP KO iBMDMs stably transduced with GFP-tagged TIRAP 
alleles that contain different lipid-binding domains (depicted in the top panel). The micrographs demon-
strate selective localization of TIRAP dependent on its lipid-binding domain. All images are representative 
of at least three independent experiments where over 200 cells were examined per condition and >95% of 
the cells displayed similar staining.
(B) Cells from (A) were stimulated with LPS or CpG DNA and analyzed by qPCR. Note that selective 
binding of TIRAP to distinct lipids permits signaling from distinct compartments.
(C) Cells from (A) were stimulated with LPS or CpG DNA for 1 hr, and myddosome formation was 
assessed.
C
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called PX-TIRAP. This adaptor has the localization domain of p40-phox, which binds 
exclusively to PI(3)P on endosomes 93,204. PX-TIRAP was of particular interest because 
of our finding that TIRAP preferentially regulates IFNα expression induced by TLR7 and 
TLR9 (Figure 2.1D), which occurs from endosomes containing 3’ phosphoinositides in 
pDCs 78. Finally, SLP2a-TIRAP was generated, which binds PS, a general component 
of the cell surface and endosomal membranes 208. These constructs were fused to GFP, 
stably transduced into TIRAP KO iBMDM and sorted by FACS to isolate clones of 
comparable expression levels. The resulting cell populations were examined by 
confocal microscopy, which verified their expected localization (Figure 2.5A, bottom 
panel). PLC-TIRAP was detected primarily at the cell surface, PX-TIRAP was enriched 
on intracellular vesicles previously identified as endosomes 204, and SLP2a-TIRAP was 
detected at the cell surface and endosomes.  
This set of stable macrophage lines was stimulated with LPS or CpG DNA to determine 
which lipids were important for TLR signal transduction. As expected, TIRAP KO cells 
expressing WT TIRAP regained the ability to permit TLR4 signaling from the cell surface 
and TLR9 signaling from endosomes (Figure 2.5B). The cell surface-exclusive PLC-
TIRAP restored responsiveness to the TLR4 ligand LPS, but interestingly, this allele did 
not restore TLR9 signaling in response to CpG DNA (Figure 2.5B). These data indicate 
that whereas PI(4,5)P2 binding by TIRAP is sufficient for signaling from the plasma 
membrane, it is not sufficient for signaling from endosomes. Remarkably, examination 
of the function of PX-TIRAP yielded the opposite results. TIRAP KO cells expressing 
PX-TIRAP (localized to endosomes via PI(3)P), responded robustly to CpG DNA but did 
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not respond to LPS (Figure 2.5B). Similar results were obtained with the PS-binding 
SLP2a-TIRAP allele (Figure 2.5B).  
The localization of TIRAP was also critical for myddosome formation. Consistent with 
Figure 3B, TIRAP KO cells reconstituted with WT TIRAP formed myddosomes in 
response to both LPS and CpG DNA (Figure 2.5C). By contrast, PLC-TIRAP was able 
to rescue myddosome formation solely in response to LPS, while PX-TIRAP and 
SLP2a-TIRAP were able to rescue myddosome formation in response to CpG DNA, but 
not LPS (Figure 2.5C). Overall, these data establish that distinct targets of the 
promiscuous TIRAP lipid-binding domain are functional, and allow this adaptor to 
promote TLR signaling from more than one site in the cell.  
2.4 Discussion 
It has become clear in recent years that TLRs can induce signal transduction from 
diverse locations in the cell, with the cell surface and endosomal membranes being the 
best-defined sites 79. However, the question remained as to how this diversification of 
receptor locale can be accommodated with the common need to activate MyD88-
dependent signaling. Our finding that TIRAP can function as a sorting adaptor for 
MyD88 at the cell surface and endosomes provides a molecular explanation to this 
question and fills an important gap in our knowledge of how diverse subcellular 
compartments can support TLR signaling.  
Several lines of evidence indicate that TIRAP can function from endosomes. First, 
TIRAP KO primary and immortal BMDM are defective for TLR signaling in response to 
HSV infection. This finding is in contrast to results obtained with non-degradable nucleic 
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acids containing phosphorothioate linkages, which bypass the need for TIRAP in 
primary BMDM. These data highlight the utility of natural activators of innate immunity to 
dissect TLR signal transduction pathways. Second, TIRAP is expressed in cells that do 
not express plasma membrane-localized TLRs (pDCs), and TIRAP KO pDCs are 
defective for IFN responses induced by TLR7 or TLR9. Because plasma membrane-
localized TLRs are not functional in pDCs, these data eliminate any possibility that 
contaminating TLR2 or TLR4 ligands can explain our findings. Third, TIRAP is a 
component of myddosomes induced by TLR4 and TLR9, and is required for their 
formation. Collectively, using multiple activators, assays and cell types, these data 
establish that TIRAP has a widespread role in controlling TLR signal transduction in 
response to bacteria and viruses.  
We do note however, that not all MyD88-dependent responses are mediated by TIRAP. 
In addition to the MyD88-dependent signaling pathways activated by the IL-1 receptor 
(IL-1R) family 152,196, we found that TLR7/9-induced IL-12p40 expression in pDCs was 
TIRAP-independent. This finding is in contrast to TLR7/9-induced IFNα expression in 
the same cells. Thus, like TLR4 169, at least some endosomal TLRs may engage distinct 
sorting adaptors to induce compartment-specific cellular responses. The sorting 
adaptor(s) that mediates MyD88 recruitment to these TIRAP-independent receptors 
remains unknown. An alternative explanation to these observations is that endosomes 
which induce IL-12p40 expression may contain higher concentrations of TLR ligands 
than IFN-inducing endosomes, rendering some signaling pathways more dependent on 
TIRAP than others. While it is formally possible that some TLRs simply recruit MyD88 to 
their cytosolic TIR domains directly (bypassing the need for a sorting adaptor), the 
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increasing incidence of sorting adaptor dependence for MyD88 recruitment makes this 
possibility unlikely.  
TIRAP is one of numerous phosphoinositide-binding proteins that can bind to multiple 
lipids 205. This promiscuity of lipid binding has been a point of inquiry, as we and others 
have suggested that PI(4,5)P2 is mainly responsible for controlling its localization and 
function 155,204. Our finding that a PI(4,5)P2-specific allele of TIRAP is sufficient to 
support TLR4 signaling is consistent with this idea. However, PI(4,5)P2-specific alleles 
of TIRAP cannot support TLR9 signaling. These observations argue strongly that the 
role of TIRAP in TLR signaling from endosomes involves interactions with lipids other 
than PI(4,5)P2. Our functional analysis of TIRAP alleles that bind to single lipids 
revealed that PI(3)P and PS are sufficient to support TLR9 signaling. From these data, it 
becomes clear that multiple targets of the lipid-binding domain of TIRAP are functionally 
important.  
The analysis of TIRAP alleles that bind single lipids was also informative in considering 
the precise subcellular sites of TLR signaling. We found that PI(4,5)P2-specific and PS-
specific alleles of TIRAP are localized to the plasma membrane, but only PI(4,5)P2 
specificity confers LPS responsiveness. Because the PS-specific TIRAP allele is 
functional when the correct stimulus is applied to the cells (CpG DNA), these data 
cannot be explained by this protein being misfolded or poorly expressed. Rather, these 
findings may highlight the precise requirement for TIRAP to be present in a region of the 
cell surface that is devoid of PS (or at least enriched for PI(4,5)P2). This suggestion is 
consistent with prior work demonstrating that localization of TIRAP to the plasma 
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membrane is not sufficient for TLR4 signaling 204; TIRAP must be localized to PI(4,5)P2-
rich regions specifically. Likewise, our analysis of TLR9 signaling highlights the 
importance of TIRAP localization to endosomes containing PS, the 3’ phosphoinositide 
PI(3)P, and probably PI(3,5)P2 78. These observations are of note when considering 
that the various membrane-bound organelles in mammalian cells have been proposed 
to consist of a phosphoinositide code (PI code) 209. This PI code is “read” by various 
lipid-binding proteins to assemble different protein structures on different membranes, 
effectively allowing the PI code to determine (in part) the activities of each organelle 209. 
Our analysis of this PI code, through the use of TIRAP alleles that bind to single lipids, 
provides a functional means to identify the precise subcellular sites of TLR signal 
transduction. We suggest that a comprehensive map of the sites of innate immune 
signal transduction can be created by further study of the link between the PI code and 
sorting adaptor localization.  
From a broader perspective, this new function for TIRAP in controlling TLR signaling 
from multiple organelles is reminiscent of the activities of the protein MAVS, the 
receptor-proximal adaptor in the antiviral RIG-I like Receptor signaling pathway105. Both 
MAVS and TIRAP can be considered sorting adaptors, in that they define the 
subcellular sites of signal transduction induced by their respective upstream receptors. 
Like TIRAP, MAVS is located on several organelles in the cell, all of which are important 
for antiviral signal transduction 62,105,210. Thus, a common theme appears to be 
emerging whereby the sites of innate immune signal transduction can be diversified 
simply by altering the subcellular sites of sorting adaptor residence.  
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In summary, we have revealed a novel means by which a promiscuous lipid-binding 
protein can be used in nature. We suggest that the sorting adaptor TIRAP evolved 
specifically to survey multiple organelles for the presence of activated TLRs. In this 
context, the promiscuity of lipid binding by TIRAP provides a molecular explanation for 
how the subcellular sites of TLR signal transduction are so diverse. Our work also 
demonstrates a novel means by which functional diversity can be achieved at the level 
of a single protein, as TIRAP can now be considered to function in bacterial detection at 
the plasma membrane and virus detection in endosomes. These studies therefore 
highlight how promiscuity, rather than specificity, can be beneficial in biological systems, 
and provide a mandate to examine the function of other promiscuous lipid-binding 
proteins in the innate immune system, and beyond.  
2.5 Materials and Methods 
Cell culture, stable transductions, microscopy 
WT (C57B/6) and TIRAP KO iBMDM were a gift from D. Golenbock (UMass) and were 
cultured in complete DMEM (Gibco) containing 10% FBS and 5% L929 conditioned 
supernatant. Primary BMDM from WT (C57B/6) or TIRAP KO mice (Jax 017629) were 
prepared as described 204. Cells were stimulated LPS (Invivogen) at 100ng/mL or 
phosphorothioate-linked CpG DNA (TCCATGACGTTCCTGACGTT (MGW Operon) at 
1µM, unless otherwise indicated.  
TIRAP alleles were introduced into TIRAP KO iBMDM by retroviral transduction and 
sorted by FACS to normalize GFP expression. When biotin-based myddosome 
isolations were performed, TIRAP alleles were introduced in iBMDM stably expressing 
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the biotin ligase BirA. Where indicated, cells were fixed with 2% paraformaldehyde and 
stained with anti-GFP (Clontech) according to manufacturer’s instructions. Antibody 
staining was detected with the secondary antibody labeled with Alexafluor-488 and 
analyzed by confocal microscopy. 
Primary BMDM were transfected by nucleofection using mouse macrophage 
transfection reagent (Lonza VPA-1009) according to manufacturer's instructions. Cells 
were imaged 4 hours later by confocal microscopy. Where indicated, dextran-Alexa 
Fluor 647 (Life Technologies) was used at 10µg/mL. 
Flt3 ligand-induced bone marrow derived pDC culture 
Bone marrow cells were isolated and cultured for 7 days in RPMI supplemented with 
10% FBS, 50 units/mL penicillin, 50µg/mL streptomycin, 10mM HEPES (Invitrogen) and 
2-mercaptoethanol (Sigma) and 100ng/mL Flt3-ligand (GEMINI). On day 8, cells in the 
supernatant were harvested, counted and plated for subsequent experiments. 
Viral infections 
KOS A, KOS CE, and KOS K (Sato et al., 2006) viruses were propagated and titered on 
Vero cells as described 211. The ICP0-null (7134) and restored (7134R) virus was grown 
and titred on U2OS cells 212. Virus was diluted in PBS containing 0.1% (wt/vol) glucose 
and 1% (vol/vol) heat-inactivated FBS. Cells were infected at the MOI indicated for 1 h 
at 37 °C, washed twice with PBS, and overlaid with DMEM containing 1% (vol/vol) heat-
inactivated FBS. Infected cells were incubated at 37 °C for the indicated length of time. 
2x106/well pDCs were stimulated with either 2x106 PFU (plaque forming unit) of HSV-2 
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(186 syn+) or 2x107 PFU of Influenza A/PR/8 for 24 hours. Supernatant was then 
harvested and ELISA was performed to measure IFN-α and IL-12p40. BMDM were 
infected with the Type 3 Dearing strain of reovirus at MOI: 10, 100 or 1000 for 3 hours, 
and analyzed by qPCR as described below.  
Microarray sample generation, data acquisition and processing 
pDC and cDC samples for microarrays were generated as described 213. In brief, DPE-
GFPxRAG1-/- transgenic mice 214,215, in which pDCs are identified by GFP expression 
(Iparraguirre et al., 2008) were injected with Flt-3ligand-expressing B16F10 tumor cells 
for expansion of DC subsets. 12-14 days later, spleens were harvested and stained for 
CD11b and CD11c. pDCs and cDCs were sorted using a MoFlo cell sorter 
(DakoCytomation) based on high GFP expression and a CD11chiCD11bhi phenotype, 
respectively. Samples were prepared in 2 independent experiments. Total RNA, 
isolated with the RNeasy kit (Qiagen), was processed, amplified, labeled and hybridized 
to mouse MOE430v2 GeneChip microarrays (Affymetrix) by the University of 
Pennsylvania Microarray Core Facility using standard protocols. Data were processed 
using Affymetrix GeneChip Operating System v1.4 software, and probe intensity files 
(.cel files) were imported and analyzed in Partek Genomics Suite (v6.6, Partek). Data 
were log2-transformed and normalized with GC Robust Multi-Array Averaging (GCRMA). 
Significance Analysis of Microarrays (SAM, samr v2.0, Stanford University) 216 was 
applied to identify differentially expressed genes in mDCs and pDCs. The most 
significant probe set for each gene of interest was used to calculate fold-changes (in 
Partek) between gene expression levels in mDCs versus pDCs that were graphed using 
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Prism software (v. 5.0c, GraphPad Software). Microarray data sets are available 
through the Gene Expression Omnibus (GEO); accession number GSE50436. 
Phagocytosis assay 
5x105 cells were kept on ice in 500uL of complete media (described above) and 
incubated with Fluoresbrite Carboxy YG 2.0 micron beads (PolySciences) at 10 
beads/cell. Cells were added to a 37oC water bath for indicated times. Phagocytosis 
was stopped with ice-cold PBS. Cells were washed 3x with ice-cold PBS, and analyzed 
by FACS.  
Myddosome isolation assay 
Cells were plated on 10cm tissue-culture treated dishes and grown to confluency (107 
cells/plate overnight). Cells were stimulated with ligand as indicated, then lysed in 
700µL of buffer containing 1% NP-40, 50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 10% 
glycerol and protease/phosphatase inhibitors (Roche). 100 µL of cleared lysate was 
retained for analysis (input) and remaining 600µL was incubated overnight at 4oC with 
1µg anti-MyD88 (R&D sciences) or anti-IRAK2 (ProSci). The following day, 50µL of 
protein G sepharose (GE healthcare) was added for 1 hour. Alternatively, cleared 
lysates were incubated with Neutravidin agarose beads (Thermo) for 2 hours. Beads 
were washed 3x with lysis buffer, then proteins were extracted by adding 50µL 2x 
Laemmli buffer, electrophoresed and immunoblotted with the indicated antibodies using 
standard conditions. The following antibodies were used: anti-MyD88 (R&D), anti-IRAK2 
(Prosci), anti-HA (3F10, Roche), anti-GFP (JL-8, Clontech) and anti-actin (ac-15, 
Sigma). Anti-IRAK4 was kindly provided by Shizuo Akira. 
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Real time quantitative PCR 
Total RNA was extracted from 2×106 cells using RNA Bee (Tel-Test Inc) according to 
manufacturer’s instructions and analyzed with TaqMan one-step qPCR reagents. 
Expression was plotted relative to GAPDH, shown as mean and standard deviation of 3 
technical replicates. Each graph is representative of at least 3 independent experiments. 
Plasmids 
TIRAP-TAP IRES GFP was produced as follows. Human TIRAP was appended with 
3xHA and a BirA target site 217,218 by overlap extension PCR. The biotin ligase BirA 218 
was subcloned into pMSCV2.2 by standard procedures.  WT TIRAP-GFP, PLC-TIRAP-
GFP and PX-TIRAP-GFP were described previously 204, and are present in the retroviral 
vector MSCV202 IRES-hCD2. pEGFP-N1-based TIRAP loc-GFP (amino acids 1-85 of 
TIRAP fused in frame to GFP) was described 204. SLP2a-TIRAP-GFP was cloned 
similarly to the TIRAP alleles described above. Briefly, the C2A domain of murine 
SLP2a was cloned from a murine spleen cDNA library and fused in frame to amino acid 
86 of TIRAP-GFP. This SLP2a-TIRAP-GFP fusion cDNA was then subcloned into the 
retroviral vector MSCV2.2 IRES-hCD2. mCherry-PH was purchased from Addgene 
(plasmid 36075). 
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Chapter 3: Loss of TIRAP Links Endotoxin Tolerance and Superinfection 
3.1 Abstract 
The inflammatory response evolved to clear our bodies of perceived threats such as 
bacteria or viruses. This inflammatory response can also result in “innocent bystander” 
effects where our own tissues can become damaged. To prevent tissue damage and 
other injury, the immune system has evolved negative feedback mechanisms to prevent 
runaway activation and limit the deleterious effects of inflammation. However, one major 
consequence of negative regulation of inflammation is a decreased ability to respond to 
repeated infections. Here, we show a novel regulatory mechanism by which multiple 
infectious stimuli cause cells to degrade TIRAP, a critical adaptor downstream of TLRs, 
resulting in suppression of TLR responses that normally lead to inflammation. 
Degradation of TIRAP requires two independent stimuli: a TLR signaling event and 
exposure to type-1 IFNs. We show that TLR4, which is known to lead to both of these 
signals, results in degradation of TIRAP and an “endotoxin-tolerant” state. However, 
signaling through other TLRs in response to viral infection, which also stimulates cells to 
produce IFNs, can serve as the necessary triggers for TIRAP degradation and negative 
regulation of TLR signaling pathways. The data presented in this chapter describe a 
previously unrecognized regulatory mechanism for altering the inflammatory response 
after initial TLR stimulation and may have implications for treatment of sepsis and 
microbial super infection.  
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3.2 Introduction 
Though inflammation plays a critical role in the normal clearance of infectious 
microorganisms, it can also cause severe damage to host tissues. Numerous examples 
of pathophysiology have been linked to excess inflammation including sepsis, a 
constellation of clinical symptoms associated with disseminated bacterial infections 219. 
Despite decades of history in treating septic patients, few clinical interventions are 
successful, and sepsis remains a leading cause of death and one of the leading 
monetary expenditures in hospitals around the world. 
Many negative regulatory mechanisms have evolved to reign in the damage caused by 
excessive inflammation, including endotoxin tolerance (ET) 220. First described more 
than 60 years ago, ET describes a modulation of responsiveness to the bacterial outer 
membrane molecule lipopolysaccharide (LPS). Innate immune cells detect LPS through 
toll-like receptor 4 (TLR4), and when exposed to small amounts of LPS, undergo 
numerous regulatory and transcriptional changes that lead to a decrease in 
proinflammatory cytokine expression following subsequent stimulation 221. However, ET 
cells are not simply unresponsive to LPS. Instead they have an altered transcriptional 
response characterized by an increase in phagocytic and degradative potential and the 
production of anti-inflammatory cytokines. Understanding ET could improve therapeutic 
intervention in sepsis, yet despite decades of study, the molecular basis of endotoxin 
tolerance is still poorly understood 222. 
Still, numerous molecular mechanisms for ET have been proposed. For example, 
transcription factors activated by TLRs induce the transcription of negative regulators of 
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TLR signaling such as IRAK-M 223. Expression of IRAK-M correlates with ET, and 
genetic ablation at this locus leads to increased inflammatory responses in models of 
sepsis 224,225. Though IRAK-M knockout animals are incapable of inducing endotoxin 
tolerance, and IRAK-M is unique among negative regulators linked with ET in its 
demonstrated involvement in both mouse and human ET 220,226, further characterization 
of the mechanistic link between IRAK-M and ET remains lacking. In addition, 
interpreting the results of the genetic ablation of negative regulators like IRAK-M is 
complicated due to the tendency of these regulators to act early in the acute response. 
For example, IRAK-M knockout animals have elevated gene expression of 
proinflammatory cytokines within hours of LPS encounter 225. As ET is typically 
evaluated after 24-48 hours, these genetically altered ET cells have experienced a 
fundamentally different constellation of responses than WT cells. 
As with bacterial sepsis, inflammation induced by acute viral infections can be deadly, 
but many viral infections also predispose their hosts to subsequent bacterial infections. 
For example, influenza kills between 5,000 and 50,000 people in the United States each 
year, but the majority of mortality is associated with secondary pneumococcal infections 
227. The threat of these so-called "superinfections" raises a regulatory paradox for the 
immune system, since inhibiting inflammation to block damage caused by viral 
infections may render and individual susceptible to new infectious assault. 
Understanding the balance between inflammation and superinfection also raises a 
paradox for investigators, and despite its clinical importance, molecular understanding 
of the phenomenon of superinfection is also lacking 227,228. Many pathogens target 
innate immune responses for inhibition directly, making it difficult to distinguish host 
71 
regulatory responses from viral virulence strategies 109,130. In addition, responses to 
infections in vivo are complicated and varied, and alterations to innate responses may 
alter pathogen load and affect the outcome of infection for reasons unrelated to the 
pathways being investigated. Further, restoring the ability of cells to respond to 
secondary infection may lead to increased inflammatory tissue damage that will have 
adverse effects in the context of the primary infection. 
Still, as with ET, several potential mechanisms have been proposed. In the case of 
influenza, the most commonly accepted explanation is that damage to epithelial barriers 
increases potential sites of attachment for pathogenic microbes 229,230. Yet seasonal 
human influenza does not cause severe lung injury 227, and mouse models demonstrate 
that susceptibility to superinfection can persist even after viral clearance228. Other 
explanations include decreased monocyte chemotaxis 231, as well as neutrophil and 
natural killer (NK) cell dysfunction 228,232. Unfortunately, these studies are primarily 
descriptive. For example, in the study implicating NK cell dysfunction, adoptive transfer 
of naïve NK cells could protect from subsequent bacterial infection, but no explanation 
for the dysfunction of influenza-experienced cells was provided. 
Here, we report a previously uncharacterized link between the phenomena of ET and 
superinfection. By investigating the earliest events in TLR signaling in macrophages, we 
show that endotoxin tolerant macrophages lose expression of TIRAP, a key component 
of the signaling pathway downstream of most toll-like receptors. This down regulation 
requires two signals, MyD88-dependent NFκB activation, and type-1 IFN signaling. Both 
of these signals may be provided by activation of TLR4, which initiates two parallel 
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signaling pathways, the MyD88-dependent pathway activating NFκB, and the TRIF-
dependent pathway culminating in the production of type-1 IFN. These signals may also 
be provided by viral infections, which activate endosomal TLRs to provide the MyD88-
dependent response, and activate cytosolic pattern recognition receptors such as RIG-I 
to generate IFN. Together, these data suggest that TIRAP is a key focal point of 
negative regulation in toll-like receptor signaling. 
3.3 Results and Discussion 
TIRAP is lost in endotoxin tolerant macrophages 
To determine the molecular basis of endotoxin tolerance in TLR signaling, we 
investigated the ability of ET macrophages to form a myddosome in response to LPS. 
This approach has several advantages. First, in contrast to monitoring gene expression, 
which may be influenced by a myriad of regulatory processes, monitoring formation of 
the myddosome allows us to investigate the earliest intracellular event in the signaling 
pathway and thus reduces the number of factors that may influence the results. Second, 
myddosome assembly can be monitored in WT or stably transduced cells, allowing 
investigation without substantial perturbations of the cellular response. Finally, the 
regulation of early signaling events is likely to have the largest effect on downstream 
responses. Thus, the formation of the myddosome may provide a useful window into 
negative regulation in ET. 
Naïve or ET immortal macrophages were stimulated with LPS, and cells were monitored 
for their ability to form myddosome complexes. In naïve macrophages, MyD88 rapidly 
associates with IRAK4 and IRAK2 in response to LPS. By contrast, pretreatment of 
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macrophages with a low dose of LPS rendered cells unable to form myddosome 
complexes in response to further LPS treatment (Figure 3.1A). Because LPS stimulation 
results in many changes in gene expression, it is reasonable to consider that 
components of the TLR4 pathway may be down regulated in ET. We therefore 
examined the cell surface expression of TLR4 in naïve and ET macrophages. Naïve 
macrophages express high levels of TLR4, but rapidly internalize the receptor in 
response to LPS. ET macrophages displayed similar behavior (Figure 3.1B). This is 
inconsistent with a report that suggests that TLR4 is downregulated in ET peritoneal 
macrophages 139. This may reflect a difference between peritoneal and bone marrow-
derrived macrophages, or the behavior of the antibody used. The epitope recognized by 
clone MTS510 (used by Nomura et. al.) is masked when the receptor is bound to LPS, 
while that used in this study (SA15-21) is not 159,233. It is also worth noting that ET 
macrophages have altered, but not absent responses to LPS 234, suggesting that they 
are still capable of detecting LPS through TLR4. Taken together, these data suggest 
that decreased TLR4 is not a likely explanation for ET. We therefore examined the 
expression of the constituents of the myddosome in ET versus naïve macrophages. 
Apparent concentrations of MyD88 remained constant over 16 hours of LPS stimulation 
(Figure 3.1C) However, we observed that ET immortalized macrophages exhibit 
significantly reduced TIRAP protein compared with naïve cells, beginning approximately 
12 hours after initial LPS treatment. 
As TIRAP is a critical component for signaling downstream of TLR4 from the cell 
surface, but not within endosomes 154,235, decreased TIRAP expression provides a 
plausible mechanism for development of ET following LPS stimulation, since TRIF- 
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dependent signaling should be unaffected. Further, while many negative regulators 
implicated in ET are expressed within hours of LPS treatment, reduction of TIRAP 
concentration is not observed until approximately 12 hours post stimulation (Figure 
3.1C). This suggests that this form of regulation is unique to ET, and does not 
participate in the acute response. 
Loss of TIRAP is Likely Due to Degradation 
The reduction of apparent TIRAP concentration in ET could be explained by reduced 
transcription, post-transcriptional regulation such as that mediated by miRNAs or 
degradation of the translated protein. However, transcript levels were unchanged in ET 
macrophages compared to their naïve counterparts (Figure 3.2A). Further, since TIRAP 
is ectopically expressed under a constitutive promoter in the cells examined 65, loss of 
TIRAP is not likely due to changes in transcription. Similarly, translational regulation by 
miRNAs is also unlikely to explain loss of TIRAP in ET.  
According to targetscan.org, the only miRNA predicted to interact with TIRAP mRNA in 
humans and mice is miR-142-3p 236. Though this miRNA has been implicated in TLR 
responses 237, it is expressed at steady-state in dendritic cells (DCs)238, which suggests 
that its regulatory function is exerted prior to activation of TLR signaling. Further, miR-
142-3p is predicted to interact with the 3' untranslated region (UTR) of the TIRAP mRNA, 
which is not present on the HA-TIRAP construct used in Figure 3.1C. Targeting the 
3'UTR is also typical for miRNAs generally 239. Though this does not rule out the 
possibility that TIRAP is subjected to miRNA regulation, these observations suggest that 
miRNAs are not a likely candidate for explaining loss of TIRAP in ET. In order to truly  
Figure 3.2
A
B
C
D
E
F
Anti-HA
Anti-MyD88
Anti-GFP
N.S. LPS P3C CpG
P3C + 
pI:CpI:C
Anti-HA
Anti-MyD88
N
.S
.
LP
S
Anti-HA
Anti-GFP
Anti-HA
Anti-GFP
N.
S.
LP
S
P3
C
Cp
G --- LP
S
P3
C
Cp
G
+ IFN
Anti-HA
Anti-MyD88
Anti-GFP
-- Flu
UV
FluLPS -- Flu
UV
Flu
+ IFN β
Figure 3.2 TIRAP Loss in ET requires MyD88-dependent signaling and type-1 IFN
(A) Naive and ET macrophages were assessed for TIRAP expression by qPCR
(B) HA-TIRAP expressing macrophages were either treated (ET) or left untreated (N) for a total of 20 
hours hours. At 12 hours post-treatment, cells were treated with the proteasome inhibitor lactacystin, the 
caspase inhibitor ZVAD or vehical (DMSO). The presence of HA-TIRAP was assessed by western blot.
(C) Cells expressing PLC-TIRAP-HA were treated with 10ng/mL LPS for 24 hours and assessed for loss 
of the HA-expressing construct.
(D-F) HA-TIRAP expressing macrophages were treated with different combinations of TLR ligands (D) as 
well as recombinant IFNβ (E) or influenza (F) PR8 strain for 24 hours and assessed for the presence of 
TIRAP. Note that both a TLR signal and a source of type-1 IFN is required for loss of TIRAP.
N ET N ET N ET
DMSO Lac ZVAD
0.000
0.005
0.010
0.015
0.020
0.025
TIRAP
Ex
pr
es
sio
n/
GA
PD
H
WT KO
76 
77 
rule out the role of miRNAs in TIRAP loss, one could monitor loss of TIRAP in DICER 
knockdown macrophages, which should be defective for all miRNA expression240. 
The final possibility is that TIRAP is targeted for degradation in ET. Indeed, TIRAP is 
known to be the target of proteasomal degradation and cleavage by caspase-1 164,165. In 
order to determine if proteasomal degradation plays a role in ET-induced TIRAP loss, 
we treated macrophages with pharmacological inhibitors of these pathways during the 
induction of ET (Figure 3.2B). Unfortunately, these preliminary experiments were 
inconclusive. It will be possible to further examine whether TIRAP loss is the result of 
degradation through mutagenesis studies. An allele of TIRAP in which the n-terminal 
localization domain is replaced with the lipid binding domain of phospholipase C δ1 
(PLCδ1) (see Chapter 2) was lost in ET macrophages (Figure 3.2C), suggesting that 
any target of degradation must reside in the c-terminal TIR domain. Caspase-1 cleaves 
TIRAP in the TIR domain at amino acid D198, and a substitution of this residue for 
alanine renders the protein insensitive to cleavage. In principal, it should be possible to 
monitor loss of this mutant allele in ET macrophages to determine whether caspase 
cleavage is important. However, this mutant allele is not capable of rescuing signaling in 
TIRAP knockout macrophages, and caspase-1 knockout macrophages appear to be 
defective for TIRAP-dependent responses 165, suggesting that cleavage is somehow 
critical for TIRAP's function. Since degradation of TIRAP may require participation in a 
signaling complex, negative results in this proposed experiment will be difficult to 
interpret. Investigating degradation by the proteasome may be equally problematic. 
Proteins are targeted for proteasomal degradation by the attachment of polybuquitin 
chains to lysine residues 241. The TIR domain of human TIRAP contains 3 lysines 153, 
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which could be mutated to arginines to abolish polyubiquitin attachment. If this mutant 
allele is not lost in ET, presuming that it is capable of participating in signaling 
downstream of TLR4, this result would suggest that proteasomal degradation is 
responsible. 
Loss of TIRAP Requires TLR signaling and type-1 interferon 
We next considered what signaling events downstream of LPS might initiate the loss of 
TIRAP. LPS binding to TLR4 activates two distinct signaling pathways: a MyD88-
dependent pathway that activates NFκB and AP-1 transcription factors and the 
production of pro-inflammatory cytokines, and a TRIF-dependent signaling cascade 
culminating in the activation of IRF3 and the production of type-1 IFN 149. Aside from 
TLR4, all TLRs activate either MyD88-dependent or TRIF-dependent signaling but not 
both 91. It is therefore possible to study these pathways in isolation. To determine 
whether MyD88 signaling alone was sufficient to induce loss of TIRAP, we chose to 
investigate TLR2 and TLR7, both of which activate the MyD88-dependent pathway. 
Treatment of macrophages with the TLR2 ligand PAM3CSK or the TLR9 ligand CpG 
DNA was not sufficient to induce loss of TIRAP (Figure 3.2D). To determine whether 
TRIF signaling alone is sufficient, macrophages were treated with poly I:C, which 
activates the TRIF-dependent pathway downstream of TLR3. As with MyD88-
dependent signaling, TRIF signaling alone was not sufficient to induce loss of TIRAP. 
Strikingly, though neither MyD88- nor TRIF-dependent signaling was sufficient, 
simultaneous induction of both pathways by treatment with poly I:C and CpG DNA 
caused loss of TIRAP comparable to that caused by LPS treatment (Figure 3.2D).  
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As noted above, MyD88-dependent signaling principally activates NFκB and AP-1 
transcription factors, while TRIF-dependent signaling principally activates IRF3 and 
type-1 IFN. The requirement for both signaling pathways suggests a number of 
possibilities. First, the production of the TIRAP eliminating factor(s) may require the 
activation of multiple transcription factors. However, though TRIF signaling downstream 
of TLR3 uniquely activates IRF3, it is also capable of activating NFκB and AP-1, 
suggesting that there is something unique about MyD88-dependent signaling other than 
its activation of transcription factors. Since TIRAP is involved in all MyD88 dependent 
signaling that have been described 65, this may imply that TIRAP must be involved in 
signaling in order to be targeted. One way to test this would be to express a mutant 
allele of TIRAP that cannot interact with the TIR domain of TLR4, which should resist 
elimination in ET if this hypothesis is correct. Another possibility is that some product of 
TRIF signaling, rather than activation of IRF3 is sufficient. Since type-1 interferon is the 
principal secreted factor downstream of IRF3, and because IFN receptor (IFNAR) 
knockout mouse macrophages are resistant to tolerance induction 242, we hypothesized 
that IFN alone might substitute for TRIF-dependent signaling. Indeed, treatment of 
macrophages with recombinant IFNβ could substitute for TLR3-mediated TRIF signaling 
and induce loss of TIRAP in combination with either TLR2 or TLR9 signaling (Figure 
3.2E), suggesting that TRIF signaling itself is dispensable in ET provided cells are in the 
presence of type-1 IFN.  
Since MyD88-dependent signaling in the presence of IFN is not unique to LPS signaling, 
we next considered whether TIRAP loss could be observed in response to other stimuli. 
In particular, many viral infections trigger MyD88-dependent TLR signaling in 
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macrophages, as well as the production of type-1 IFN downstream of cytosolic RNA or 
DNA sensors 94,243. This possibility is especially intriguing since viral infections such as 
influenza may render their hosts more susceptible to bacterial infection 227, a 
phenomenon that could be partially explained by loss of TIRAP and insensitivity to TLR 
ligands. In addition, influenza infection desensitizes mice to TLR stimulation, though an 
unknown mechanism 244. To assess whether viral infections could induce loss of TIRAP, 
HA-TIRAP expressing immortalized macrophages were infected with the mouse-
adapted influenza strain PR8 and assessed for the presence of TIRAP. As expected, 
PR8-infected macrophages lost TIRAP to a similar extent as ET macrophages (Figure 
3.2F). This loss was further exacerbated by the addition of exogenous recombinant 
IFNβ. 
TIRAP Modulates Responses to Influenza In Vivo 
The role of TLR signaling in the clearance of influenza is unclear. In one study, either 
MyD88- or MAVS-dependent signaling alone was sufficient to control infection, while 
mice doubly deficient for both MAVS and MyD88 were susceptible243. Contradicting this 
finding, a similar study showed that TLR7 or MyD88 KO mice were significantly more 
susceptible to influenza than their WT counterparts245. Yet another study demonstrated 
that TLR7 knockout mice were no more susceptible to influenza infection, but were 
moderately protected from secondary bacterial infection after influenza challenge 246. 
This latter result supports our hypothesis that TIRAP loss may be important in 
superinfection, since TLR7 KO mice should be unable to provide the MyD88-dependent 
signal required to cause loss of TIRAP.  
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To date, no one has assessed the role of TIRAP in influenza infection. In order to 
assess the role of TIRAP in controlling influenza infection in vivo, WT and TIRAP 
knockout animals were infected intratracheally at LD80 with strain A/Puerto Rico/8/1934 
H1N1 (PR8), and assessed daily for weight loss247. 80% initial body weight was the 
clinical endpoint. WT animals dropped to 80% initial bodyweight by day 8 post infection 
(n=6), while TIRAP knockout animals exhibited a slight decrease in body weight but 
began to recover after 8 days (n=5) (Figures 3.3A). In accordance with the protocol, all 
WT mice were sacrificed on day 8 at 80% initial body weight, while TIRAP KO mice 
appeared to recover (Figure 3.3B). These results suggest that the inflammation induced 
by TLR responses to influenza may contribute to viral damage, and loss of TIRAP could 
be a regulatory strategy to reduce this damage.  
This hypothesis raises several questions that have yet to be tested. Are TIRAP KO mice 
still able to induce robust adaptive immune responses? The role of TLR signaling in the 
production of protective antibodies is contested. One study showed that loss of MyD88 
or TLR7 altered antibody isotype skewing, but had no effect on protection from 
secondary challenge, while a similar study showed that the same knockout mice were 
significantly more susceptible to secondary challenge 243,248. Does TLR signaling help 
control viral load? As noted above, MyD88 and TLR7 deficient mice are similarly able to 
control primary challenge, provided RLR signaling is intact. However, all of these 
studies use different initial viral load and route of administration, so direct comparison is 
problematic. 
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Taken together, these data suggest a possible link between ET and virus-induced 
superinfection, since viral infection provides the signals required for ET-mediated TIRAP 
loss (Figure 3.3C). Once the mechanism of TIRAP degradation is identified, this link 
could be validated by expression of an allele of TIRAP that resists degradation in ET, or 
removal of a factor responsible for this degradation. We would predict that blocking 
TIRAP loss in ET would protect against superinfection, though this might increase 
inflammation-related pathologies of the viral infection itself. These results are 
particularly exciting in light of the clinical challenges of superinfection. Though the 
increase in susceptibility to bacterial infection is likely multifactorial, regulation of TIRAP 
may be a promising target of pharmacologic inhibition. Enhancing immune responses is 
often problematic, since lowering the threshold of inflammation can lead to inflammatory 
pathology. However, because TIRAP loss does not appear to regulate acute 
inflammatory responses, disruption of this regulatory pathway is less likely to promote 
spurious responses.  
3.4 Materials and Methods 
Cell culture, stable transductions 
WT (C57B/6) and TIRAP KO iBMDM were a gift from D. Golenbock (UMass) and were 
cultured in complete DMEM (Gibco) containing 10% FBS and 5% L929 conditioned 
supernatant. Primary BMDM from WT (C57B/6) or TIRAP KO mice (Jax 017629) were 
prepared as described (Kagan and Medzhitov, 2006). Cells were stimulated LPS 
(Invivogen) at 100ng/mL or phosphorothioate-linked CpG DNA 
(TCCATGACGTTCCTGACGTT (MGW Operon) at 1µM, unless otherwise indicated. 
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TIRAP alleles were introduced into TIRAP KO iBMDM by retroviral transduction and 
sorted by FACS to normalize GFP expression. Unless otherwise stated, endotoxin 
tolerant macrophages were generated by culturing cells with 10ng/mL for 24 hours.  
Myddosome isolation assay 
Cells were plated on 10cm tissue-culture treated dishes and grown to confluency (107 
cells/plate overnight). Cells were stimulated with ligand as indicated, then lysed in 
700µL of buffer containing 1% NP-40, 50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 10% 
glycerol and protease/phosphatase inhibitors (Roche). 100 µL of cleared lysate was 
retained for analysis (input) and remaining 600µL was incubated overnight at 4oC with 
1µg anti-MyD88 (R&D sciences) or anti-IRAK2 (ProSci). The following day, 50µL of 
protein G sepharose (GE healthcare) was added for 1 hour. Alternatively, cleared 
lysates were incubated with Neutravidin agarose beads (Thermo) for 2 hours. Beads 
were washed 3x with lysis buffer, then proteins were extracted by adding 50µL 2x 
Laemmli buffer, electrophoresed and immunoblotted with the indicated antibodies using 
standard conditions. The following antibodies were used: anti-MyD88 (R&D), anti-IRAK2 
(Prosci), anti-HA (3F10, Roche), anti-GFP (JL-8, Clontech) and anti-actin (ac-15, 
Sigma). Anti-IRAK4 was kindly provided by Shizuo Akira. 
TLR4 Surface Expression 
WT macrophages were treated with 10ng/mL LPS or left untreated for 24 hours. Cells 
were washed and incubated with DMEM for 30 minutes, and then stained with anti-
TLR4 (SA15-21) PE 159,233. 
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Real time quantitative PCR 
Total RNA was extracted from 2×106 cells using RNA Bee (Tel-Test Inc) according to 
manufacturer’s instructions and analyzed with TaqMan one-step qPCR reagents. 
Expression was plotted relative to GAPDH, shown as mean and standard deviation of 3 
technical replicates. Graph is representative of 2 independent experiments.  
Plasmids 
TIRAP-TAP IRES GFP was produced as follows. Human TIRAP was appended with 
3xHA and a BirA target site (de Boer et al., 2003; Mechold et al., 2005) by overlap 
extension PCR. The biotin ligase BirA (Mechold et al., 2005) was subcloned into 
pMSCV2.2 by standard procedures. 
Influenza infections 
WT (C57/B6) and TIRAP KO (Jax 017629) were infected intratracheally at LD80 with 
strain A/Puerto Rico/8/1934 H1N1 (PR8), and assessed daily for weight loss. 80% initial 
body weight was the clinical endpoint 247. Macrophages were infected at a multiplicity of 
infection of 100.  
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Chapter 4: Perspectives on the Future of Innate Immune Signaling Research 
4.1 Introduction 
Twenty-five years ago, Charles Janeway stood in front of a room full of immunologists, 
flatly declared that there would be no further revolutionary changes in our understanding 
of immune recognition and then immediately proceeded to launch just such a revolution. 
Our understanding of microbial recognition by the germline encoded pattern recognition 
receptors that Janeway predicted has changed how we perceive adaptive immune 
responses, self versus non-self recognition, immunological development and much 
more. Many of the advances in innate immunity research are the product of the modern 
genomics era, where gene knockouts are commonplace, and computational 
approaches can identify structurally related factors. However, as I stated in the 
introduction to this document, I believe we are approaching another asymptote, where 
genetic dissection of innate immune signaling pathways will no longer yield 
straightforward results. 
Yet many exciting research avenues remain, where understanding will lead to profound 
changes in human health. In particular, we must move away from studying individual 
genes or gene products in isolation, and move towards understanding the complex 
interactions in their natural context. For example, understanding how 
compartmentalization within an individual cell governs the behavior of signaling 
pathways may yield insight into how the quality and magnitude of responses to 
particular ligands in particular contexts is determined (Chapter 4.2). These same studies 
may also improve our understanding of cell-type specific responses, since certain cell 
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types may contain the same basic protein components, while organizing them differently 
within the cell for different responses. Another fruitful investigative path is in 
understanding the mechanisms for integrating multiple signals to coordinate a unified 
response to pathogens. Our innate immune cells did not evolve to respond to purified 
LPS or synthetic nucleic acid oligos, but must instead interrogate many PAMPs from the 
same pathogen and use this complex mix of signals to provide the appropriate response 
(Chapter 4.3). This response may be complicated by the presence of multiple 
pathogens, as in the case of superinfection, as well as the presence of non-infectious 
microbes that nevertheless present PAMPs. Finally, the insight gained from basic 
studies of the innate immune system must be translated to improve human health. 
Despite 25 years of study into the mechanisms of innate immune detection, no new 
vaccine adjuvants have been approved for use in the United States, and few therapies 
incorporate an understanding of the earliest events in an immune response. In addition, 
the etiology of inflammatory disorders and autoimmune disorders remains unclear, 
though they must involve an initial inflammatory insult mediated by the innate immune 
system. 
4.2 Cellular Compartmentalization and Innate Immune Signaling 
Localization of TLR Sorting Adaptors 
In Chapter 2, we demonstrated that the compartmentalization of TIRAP is more 
complicated than previously appreciated (Figure 4.1A). Though TIRAP can bind to 
multiple lipids in vitro, its lipid binding domain was initially thought to bind exclusively to 
PI(4,5)P2 in vivo, localizing it to the plasma membrane 204. There were several reasons  
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(A) Model for the role of TIRAP in TLR signaling from the plasma membrane and endosomes. TIRAP is 
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factor that targets TIRAP for degradation (left panel). Alternatively, each signaling pathway may produce 
factors that are individually required to target TIRAP (center panel). Finally, IFN signaling may produce a 
factor that targets TIRAP, but only when it is in an active signaling complex (right panel)
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for the original interpretation. First, though many phophoinositide-binding proteins have 
promiscuous binding in vitro, many have higher affinity for a single lipid species, which 
determines their in vivo function 205. Second, an allele of TIRAP in which the lipid 
binding domain was replaced with that of PLCδ1, which exclusively binds PI(4,5)P2, 
was capable of rescuing all known functions of TIRAP. However, the novel finding that 
TIRAP is required for signaling downstream of endosomal TLRs called this 
interpretation into question (Chapter 2 and 65). Since PI(4,5)P2 is primarily found at the 
plasma membrane, PI(4,5)P2-localized TIRAP should not be able to function from 
endosomal compartments. Indeed, we found that PLC-TIRAP was not capable of 
rescuing signaling downstream of the endosomal TLR9, while an allele of TIRAP that 
localized to PI(3)P (primarily localized to endosomes) or PS could signal downstream of 
TLR9, but not TLR4 (Figure 2.5). 
TIRAP binds to PI(3)P and PS in vitro (Figure 2.4), but the ability of multiple lipid-binding 
domains to rescue the endosomal signaling of TIRAP does not prove that these are the 
natural lipid targets in vivo, as it is possible that any endosomal localization is sufficient 
for TIRAP’s ability to signal downstream from this location. If true, this would seem to be 
in contrast to TIRAP’s plasma membrane function, since targeting TIRAP to the plasma 
membrane is not sufficient to recapitulate its function. For example, in Kagan et al 2006, 
a construct in which the localization domain of TIRAP was replaced with that of the 
kinase Fyn could not rescue TLR4 signaling. This construct seems ideal, since Fyn not 
only localizes to the plasma membrane, but localizes to the same subdomain of the 
plasma membrane as PI(4,5)P2 159,249. However, Fyn’s localization domain requires 
both myristolation and farnesylation, which causes it to integrate with the inner leaflet of 
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the plasma membrane 250. These modifications may produce steric hindrance or in 
some other way prevent TIRAP’s association with the TIR domain of the TLR, even if 
they are in close proximity. In light of this, the results obtained in Figure 2.5B and 2.5C 
are ideal, since each construct was capable of signaling from either the plasma 
membrane or endosomes, indicating that negative results cannot be explained by 
misfolding or inability to interact with TLR TIR domains. Unfortunately, though PS is 
found at the plasma membrane, it is not found in lipid rafts from which TLR4 initiates 
signaling, so whether PI(4,5)P2 binding in particular is important is still an open question. 
Implications of TIRAP Involvement in pDCs 
Our work detailed in Chapter 2 raises other questions as well. We showed that TIRAP 
was important for initiating signaling from endosomal TLRs in macrophages, as well as 
to initiate the IFN-producing pathway in pDCs (Figure 2.1). However, there was no 
defect in the ability of pDCs to produce inflammatory cytokines downstream of 
endosomal TLRs. As the inflammatory pathway and IFN pathway are initiated from 
different endosomal compartments (see Chapter 1.5), there are several possible 
interpretations. The first is that TIRAP is required to recruit MyD88 to the so-called 
“IRF7 endosome” to trigger production of IFN, but no sorting adaptor is required for the 
“NfκB endosome to produce inflammatory cytokines. However, it seems increasingly 
clear that all TIR-domain containing receptors (save TLR3) require a sorting/signaling 
adaptor pair, including all TLRs studied in macrophages, IL-1/IL-18R and Drosophila 
Toll 160,197. That later example is especially convincing on this point, since Drosophila 
MyD88 (dMyD88) is the structural homologue of the mammalian signaling adaptor, but 
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functions in flies as a sorting adaptor. Though dMyD88 has a death domain and could in 
principal interact with the IRAK homologue pelle, flies have evolved a separate signaling 
adaptor (Tube) to mediate this interaction. The evolutionary conservation of function, 
even while the proteins carrying out those functions are diversified, argues strongly that 
sorting adaptors are critical to these signaling pathways.  
A second possibility is that some other sorting adaptor recruits MyD88 to endosomal 
TLRs in pDCs. Mouse and human genomes contain several TIR domain-containing 
proteins, many of which are poorly characterized. To date, no one has investigated the 
role of these proteins in TLR signaling in pDCs. Finally, it is possible that TIRAP is in 
fact the sorting adaptor for pDCs. The role of TIRAP in endosomal signaling in 
macrophages was unknown for a decade because of an artifact caused by the use of 
non-degradable synthetic ligands. Though pDCs in Figure 2.1D were infected with a live 
virus, it’s possible that some artifact of viral dose or cell-culture conditions masked a 
requirement for TIRAP in those cells. One way to test this hypothesis would be to 
measure the production of inflammatory cytokines by pDCs in a live viral infection by 
intracellular cytokine staining. If TIRAP is indeed required, TIRAP knockout pDCs 
should produce less proinflammatory cytokines in a natural infection.  
Further investigation of these distinct pathways in pDCs may be fruitful for 
understanding the bifurcation of production of inflammatory cytokine and type-1 IFN. 
This separation is reminiscent of TLR4 signaling in the use of separate pathways for the 
production of these factors, but differs in at least two respects. First, TLR4 uses an 
entirely different set of adaptors and signaling enzymes to initiate IFN production, while 
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endosomal TLRs in pDCs use largely the same components for both pathways (with at 
least one notable exception discussed below) 76,149,158. Second, the separation in pDCs 
cannot be explained by apparent need to restrict IFN production from signals originating 
at the cell surface (discussed in Chapter 1.5), since all TLR signaling in pDCs is 
endosomal.  
One way to address differences in these pathways in pDCs may be possible by 
investigating the divergent roles of IRAK1 and IRAK2 142,143. As described in Chapter 
1.4, while both the inflammatory and IFN-producing pathways in pDCs rely on IRAK4, 
IRAK1 is used exclusively in the production of IFN, while IRAK2 is required for 
proinflammatory cytokine production. In fact, these pathways are somewhat mutually 
exclusive, since IRAK1 knockout pDCs produce more inflammatory cytokines 
downstream of TLRs than their WT counterparts, while IRAK2 knockouts make more 
type 1 IFN than WT. Coupled with the knowledge that both of these pathways require 
MyD88, IRAK4 and TRAF6, this suggests that IFN-producing IRAK1 myddosomes may 
compete with inflammatory cytokine-producing IRAK2 myddosomes for upstream or 
downstream components.  
It is unclear whether IRAK1 and IRAK2 can be recruited to the same myddosome 
complex, though this seems unlikely as these pathways are thought to initiate from 
distinct endosomal compartments78. Precisely how IRAK1 and IRAK2 could be 
differentially recruited to different subcellular locations is unclear. This may be explained 
by the presence of a sorting adaptor other than TIRAP. However, TIRAP-containing 
myddosomes in macrophages contain IRAK2 and initiate inflammatory cytokine 
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production, while TIRAP in pDCs seems to be required solely for the IFN pathway. 
Intriguingly, the E3 ubiquitin ligase TRAF6, though typically depicted downstream of the 
IRAKs, is required for both signaling pathways 75,251. This suggests that the IRAKs may 
phosphorylate multiple targets, including those downstream of TRAF6. One possibility is 
that TRAF6 may serve as a “sorting platform” for these independent pathways. TRAF6 
contains multiple zinc finger motifs, whose functions are largely uncharacterized 252. 
Zinc finger domains function in phospholipid binding, making them ideal localization-
determining domains. Further, the closely related TRAF3 is known to exist in several 
different splice isoforms that are differentially expressed in different cell types, and 
these isoforms differ principally in their zinc finger domains 253,254. If TRAF6 also exists 
in multiple splice forms, this would raise the possibility that TRAF6 may be directed to 
different subcellular compartments and differentially mediate the recruitment or 
activation of IRAK1 and IRAK2. 
Localization in Other Innate Immune Signaling Pathways 
Less is known about the cellular compartmentalization of other PRRs, though some 
themes are beginning to emerge. Like the bifurcation of IFN and inflammatory cytokine 
production downstream TLR4 and of TLRs in pDCs, RLR signaling activates separate 
pathways depending on the localization of its adaptor protein MAVS 62,109. Unlike TLRs, 
these pathways do not differ in their ability to produce inflammatory cytokines. Rather, 
MAVS localized to mitochondria initiates the production of type 1 IFN, while MAVS 
localized to peroxisomes induces interferon-stimulated genes in a type 1 IFN 
independent manner. More recent work in our lab (unpublished) suggests that 
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peroxisomally-localized MAVS induces type 3 IFN. The reason for spatially separating 
these pathways in most cases is unknown, though one plausible explanation is the 
ability of cells to differentially regulate these pathways. In the case of TLR4, expression 
of CD14 is required to move the receptor to endosomes and initiate TRIF-dependent 
signaling, and cells lacking CD14 are incapable of triggering this pathway in response to 
LPS 159. This is true not only in genetically altered mice, but also in cells that naturally 
lack expression of CD14 such as B-cells. However, no examples of differential spatial 
regulation of RLR or pDC TLR responses have yet been described. 
4.3 Integration of Pattern Recognition Receptor Signals 
Relatively little is known about the integration of signals from multiple PRRs, yet most 
microbes naturally contain several different PAMPs. In addition, the cells of the innate 
immune system must interpret those signals in the context of cytokines and other 
signaling molecules produced by neighboring cells. Our work in Chapter 3 demonstrates 
that at least in some cases, signals downstream of multiple receptors trigger a cell 
behavior that neither signal induces on its own. In particular, macrophages receiving a 
cell-intrinsic signal from a MyD88-dependent TLR as well as extrinsic type 1 IFN lose 
TIRAP, lowering their sensitivity to future microbial encounter. We do not know whether 
macrophages can initiate this regulatory program in an entirely cell-intrinsic manner. A 
single ligand (LPS) is capable of triggering loss of TIRAP, but macrophages 
encountering LPS initiate two signaling pathways, one of which culminates in the 
production of type 1 IFN (Figure 3.3C). It’s possible that this TRIF dependent signal can 
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provide the second signal in the absence of IFN, though this could be tested by 
monitoring TIRAP loss in IFNAR knockout macrophages in response to LPS. 
While we have not experimentally tested the mechanism of TIRAP loss, our data are 
consistent with several possibilities (Figure 4.1B). First, the factor responsible may 
depend on activation signals of both MyD88-dependent TLRs and IFNAR, or on the 
combined action of transcription factors downstream of both pathways. Second, two or 
more factors may be responsible for TIRAP loss, with production or activation of at least 
one dependent on each pathway. Finally, a gene product dependent only on IFN 
signaling may target TIRAP, but only while it is part of an active signaling complex. 
Unraveling these possibilities will be challenging, but may reveal new methods of 
regulation that ultimately influence the immune response. For example, in 2005, multiple 
groups showed that integration of signals from both arms of TLR4 signaling (TRIF- and 
MyD88-dependent) led to sustained NFκB activation, rather than an oscillation in activity 
like that induced by tumor necrosis factor (TNF) 255,256. However, this did not merely 
lead to an increase in the levels of gene expression, but rather led to a qualitatively 
different response. 
Understanding the nature and magnitude of the response triggered by pattern 
recognition receptors is not merely academic, as inflammation lies at the heart of many 
of the most costly human diseases, from type 2 diabetes to autoimmunity to cancer. 
Treating disorders characterized by too much inflammation, such as autoimmunity or 
allergies, is challenging since suppressing the immune system leaves patients 
vulnerable to infectious assault. At the same time, a remedy for too little inflammation, 
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as in the case of cancer and some challenging vaccines, is also problematic since 
excessive inflammation causes tissue damage and may lead to autoimmunity. A more 
nuanced understanding of activating and inhibitory signals may allow for a clinical fine-
tuning of immune responses. Efforts at refining this understanding are already 
underway. For example, several common genetic variants in human TLR signaling 
networks cause measurable changes in responses to TLR ligands, which may govern 
differential responses to infectious challenge or vaccines 257. Similarly, genome-wide 
associate screens have identified several PRR-linked genes that increase susceptibility 
to autoimmune disorders 258-260. Though the ability to translate these findings to the 
clinic are uncertain, they highlight the limitations of the traditional genetic approaches 
that have thus far dominated the investigation of innate immune recognition.  
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Figure S1. 
Further Analysis of TLR Signaling in Primary and iBMDMs, Related to Figures 2.1 and 2.2
(A) WT or TIRAP KO primary BMDM were infected with two strains of HSV at multiple MOIs. Higher MOI 
with substrain 7134 overcomes the signaling defect in TIRAP KO BMDM.
(B) WT and TIRAP KO primary BMDM were infected with reovirus at multiple MOIs. Responses to 
reovirus were unimpaired in TIRAP KO BMDM.
(C) WT and TIRAP KO iBMDM were stimulated with increasing doses of CpG DNA (1-100 μM). TIRAP 
KO cells are defective for cytokine expression except at high ligand concentration, analogous to the 
concentration-dependence of cell-surface TLRs.
(D) iBMDM were infected with an IPC0 null (7134) or revertant (7134R) strain of HSV and transcriptional 
responses were assessed by qPCR. Error bars represent SD.
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Figure S2. 
Biochemical Analysis of TLR-Induced Myddosomes, Related to Figure 2.3
(A) iBMDM were treated with LPS for the indicated times and IRAK2 was immunoprecipitated from 
lysates and analyzed by western blot.
(B) HA-TIRAP-expressing iBMDM were treated as indicated and MyD88 was precipitated from cleared 
lysates. Immunoprecipitates were then analyzed by western blot for the indicated proteins.
Figure S2
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